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ABSTRACT 
Several unique strategies were developed and employed in the synthesis 
of 2-(1,2-dihydroxy-1-oxiranylethyl)-5-methylchromen-4-one (1) during a model 
study for the synthesis of hydramycin (2)-an antitumor antibiotic. Hydramycin, a 
pyranoanthraquinone, was isolated from a strain of Streptomyces and shown to 
exhibit both cytotoxic and antibiotic properties. This dissertation will cover the 
0 
1 2 
developments, challenges and solutions discovered in the total synthesis of 
truncated analog 1, which contains the functionality found in 2, and the 
methodology to generate an anthraquinone system that could be used for the 
ultimate synthesis of 2. 
V 
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Natural products research is continuously discovering compounds that 
exhibit biological and pharmacological activity, including antibiotic and cytotoxic 
activity. The discovery of numerous compounds that can be subjected to quick 
preliminary screening for biological activity has led to a surge in the isolation of 
potent candidates that can undergo more detailed activity studies. Along with a 
thorough pharmacophoric assessment, these detailed studies lead to complete 
structural determination which gives rise to structure-activity relationships (SAR). 
Since these isolated drug candidates have origins in biosynthesis, the 
development of suitable synthetic pathways proves to be a difficult yet crucial 
step towards the task of generating a marketable drug for cancer chemotherapy 
or antibiotic treatment. 
Much interest has been focused on the biological activity of 




ring skeleton (rings B,C and D) fused to a y-pyranone ring (ring A). Substituents 
vary greatly among known pyranoanthraquinones; however, compounds that 
1 
contain some or all of the following groups attract much attention: a methyl group 
at CS, a mutli-functionalized alkyl chain at C2 with an epoxide subunit, sugar 
moieties ( especially at ca and C 10) and a hydroxy group at C 11.1 When 
containing sugar rings, these pyranoanthraquinones are also referred to as 
pluramycins, 2 or anthra[1,2-b]pyran antibiotics; 3•4 however, when no sugar 
system is present they are referred to as pluramycinones. 5 From 
structure-bioactivity studies of pyranoanthraquinones, it was discovered that the 
epoxide subunit is critical. The epoxide serves as a site of nucleophilic attack by 
guanine N7 in duplex DNA. This covalent bonding results in effective DNA 
alkylation.s.9 These 4H-anthra[1,2-b]pyran-4,7, 12-triones have been studied for 
antitumor and antimicrobial activity since the isolation and discovery of the first 
Me 
Pluramycin A SF-2330 
bioactive pluramycin (pluramycin A) in 1956 from Streptomyces 
pluricolorescens 5•10 and the first pluramycinone (SF-2330) in 1986 from 
2 
Streptomyces sp. SF-2330. 11·12 
In 1991, one such potent pluramycinone was isolated from the 
fermentation broth of Streptomyces violaceus P950-4 (ATCC 53807) from a soil 
sample collected in Hyderabad, Andhra Pradesh State, lndia. 13 The recovered 
compound, hydramycin (2)-11-hydroxy-5-methyl-4H-anthra[1,2-b]pyran-4, 7, 12-
trione-not only displayed strong antibacterial activity against Gram-positive 
1 2 
bacteria, but showed potent cytotoxicity activity. In 1992, a screening run by the 
National Cancer Institute (NCI) indicated potent antitumor activity against 
prostate cancer with an HFA value of 16.14•15 Because of the inherent 
pharmacological activity in hydramycin and the potential for the study of the SAR 
of pluramycinones, a total synthesis seemed prudent. 
B. Outline of Employed Synthetic Strategies 
Through retrosynthetic analysis of hydramycin (Scheme 1 ), it was possible 
to envision two unique disconnections rendering two synthons: an anthraquinone 
moiety and a functionalized side chain. These two synthons could be cyclized in 
some manner to establish the pyranone ring system. There were several very 
3 
different approaches explored during the synthesis of these two synthons. These 
will be discussed in two categories-methods involving aldol chemistry and 
methods involving alkynyl coupling-each with several variations. 
1. Aldol Condensation Methods 
One pathway for the synthesis of hydramycin (Scheme 1, path a) would 
require an anthraquinone moiety containing an acetyl group at C2, which through 
aldol chemistry with an appropriate aldehyde could generate an a,J3-unsaturated 
system that could be cyclized into a pyranone ring. The appropriate functionality 
on the alkyl side chain could either be installed on the aldehyde synthon before 
the aldol reaction or after. Both possibilities will be discussed in this dissertation. 
Generation of the side chain 4 for an aldol reaction appeared to offer the 
most challenges. A decision on whether to install the functionality on the side 
chain before the condensation or add the functionality afterwards was needed 
(Scheme 2). If aldehyde 7 was condensed with an aromatic compound followed 
by cyclization, then the olefins could provide a platform for a dihydroxylation and 
an epoxidation to provide the functionality of 1. Conversely, use of aldehyde 8 
would allow the hydroxyl and epoxide group to be installed prior to condensation 
and cyclization. 
For a total synthesis of hydramycin, the anthraquinone system 3 must be 
prepared. In 1980, Hauser and Rhee3 outlined a total synthesis of 0-
methylkidamycinone, a pluramycinone without the apparently necessary epoxide 
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Scheme 1. Retrosynthetic Analysis of Hydramycin 
5 
synthetic scheme for hydramycin from Hauser's work yielded a non-convergent 
method with 24 steps. Attention was turned to developing a more convergent 
method that still used an aldol condensation for coupling. Focusing on the 
anthraquinone moiety 3 (Scheme 1, path a), there were several viable theories 
on its synthesis (Scheme 3). First, a Friedel-Crafts reaction between 1,8-
dihydro-3-methylanthraquinone (chrysophanic acid, 9), which is commercially 
available or could be synthesized, and acetyl chloride (10) could directly provide 
the desired anthraquinone 3. Second, a Diels-Alder reaction between 3-
hydroxyjuglone (11) and a properly functionalized diene (12), followed by 
aromatization, could generate the anthraquinone 3. Third, a reaction involving 
the Friedel-Crafts coupling of 3-hydroxyphthalic anhydride (13) with an 
acetophenone analog (14) might synthesize 3. Finally, 3 could be generated 
using the method developed from the O-kidamycinone synthesis; however, the 
desired convergency would be lost (Scheme 4). In a study of 9, 10-dihydro-4,5-
dihydroxy-3-malonamoyl-9, 1 0-dioxo-2-anthraceneacetic acid (protetrone ), a 
synthesis of 3 was reported; however, the original starting material was isolated 
in a metabolic biosynthesis, so this option was not explored further. 16 
Using the methodology discovered in the model studies of the aldehyde 
side chain synthon and the synthesis of anthraquinone 3, the hope was to 
develop a total synthesis of analog 1, which could lead to the eventual synthesis 
of 2. Methods utilizing the aforementioned aldol chemistry will be discussed later 
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Scheme 2. Possible Aldol Condensation Reactions 
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Scheme 3. Retrosynthetic Analysis of Anthraquinone 3 
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2. Alkynyl Coupling Methods 
Another pathway (Scheme 1, path b) for the total synthesis of hydramycin 
that was explored involved the coupling of an aldehyde at C2 of the 
anthraquinone system 5 with an alkynyl side chain synthon (6). After oxidation of 
the coupled product, pyranone ring formation could be achieved by 6-endo-
digonal closure. 17 Previously reported research on pyranoanthraquinone analogs 
suggests that if an appropriate alkyne could be generated, it would be possible to 
couple with an anthraquinone aldehyde followed by fluoride-induced pyranone 
ring closure to generate hydramycin.1·6-8 Another procedure using alkynyl 
chemistry was reported for the synthesis of pyranoanthraquinones; 1s.2o however, 
this method could not be taken advantage of because of the coupling procedure. 
The alkynyl side chain synthon appeared to show the greatest signs of 
difficulty for synthesis, since the functionality had to survive the coupling 
conditions, or be installed afterwards (Scheme 5). Through the coupling of a 
substituted benzaldehyde (27) with the organometallic salt of an alkyne 6 and 
oxidation of the resulting alcohol could give an ethynyl ketone (28). Keto-
compound 28 could be cyclized into the needed pyranone compound (29) and 
elaborated. This methodology could be employed using anthraquinone 5 leading 
to the synthesis of 2. Attention was given to a model study that could test both 
the proposed chemistry and generate an analog that could possibly aid in better 
understanding the SAR of 1. The pluramycinones contain an anthraquinone 
moiety; however, several studies have shown that the epoxide subunit off the 
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Scheme 4. Non-convergent Synthesis of Anthraquinone 3 
9 
anthraquinone ring system might not be necessary.8 
C. Dissertation Overview 
This dissertation will cover the developments, challenges and solutions 
discovered in the total synthesis of 2-(1,2-dihydro-1-oxiranylethyl)-5-
methylchromen-4-one (1) and an appropriate anthraquinone synthon for future 
elaboration into 2. The methodology developed for the synthesis of truncated 
analog 1 could be adapted into a total synthesis of hydramycin. 
10 
R 
OR 0 OR 0 
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27 6 28 29 
Scheme 5. Alkynyl Coupling and Cyclization for Pyranone Synthesis 
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II. STATEMENT OF THE PROBLEM 
A few syntheses exist for generating pluramycinones; however, these 
methods are long and designed specifically for individual structures. In addition 
these structures contain complicated functionality, which can be difficult to 
synthesize. The research goal was to develop a convergent synthetic strategy 
that installed all appropriate functionality onto an appropriate moiety. Therefore, 
this dissertation will delve into the synthetic strategies employed in the 
generation of a truncated analog (1) of hydramycin. This abbreviated analog 
contains the pyranone ring system and functionality of 2. The synthesis of an 
appropriate anthraquinone system will also be explored in this dissertation. The 
synthetic route developed could be expanded to include the full anthraquinone 
ring moiety, yielding 2 and possibly other pluramycinones. 
12 
Ill. DISCUSSION 
A. Anthraquinone Synthesis 
For the synthesis of pluramycinone analogs, there arises the need for 
properly functionalized anthraquinones. Synthesis of anthraquinones 3 and 5 are 
essential for utilizing both the aldol and alkynyl chemistry. The developments, 
complications and techniques explored during the development of these 
anthraquinones is discussed below. 
1. Diels-Alder Approach Towards Anthraquinone Synthon 3 
There have been reports of anthraquinone synthesis utilizing Diels-Alder 
chemistry; 21 therefore, such an approach for the synthesis of the anthraquinone 
synthon 3 was envisioned (Scheme 6). After preparing a Danishefsky-like 
diene 22•23 (31 ), it could be coupled to 5-hydroxy-1,4-quinone Uuglone).24-26 After 
oxidative aromatization of the Diels-Alder product, protection of 1,8-
dihydroxyanthraquinone as the methyl ether could be achieved with Mel and 
K2CO3• A lithium halide exchange and subsequent reaction with acetaldehyde, 
followed by O-demethylation, would lead to the desired anthraquinone 3. 
Through the use of bromodimethylsulfonium bromide, it was possible to 
generate the a-bromo compound 30 from acrolein.27 This was accomplished by 
generation of the electrophilic reagent from dimethyl sulfide and Br2 in CH3CN at 
low temperature. When added to an a.~-unsaturated carbonyl compound, such 
as acrolein, the electrophile adds to the unsaturation furnishing an a-bromo-~-
13 
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Scheme 6. Diels-Alder Approach to the Synthesis of Anthraquinone 3 
14 
dimethylsulfonium carbonyl compound. This compound can be subjected to 




subsequent expulsion of dimethyl suflide, leaving the 
Br desired a-bromo compound 30. Reaction of 30 with 
Me TMSCI in the presence of Et3N led to the generation 
of the trimethylsilyl enol ether 31.28·29 
The hope was to use either a catalyzed or 
uncatalyzed Diels-Alder reaction, followed by oxidative aromatization, to 
generate anthraquinone 3. It was discovered that when diene 31 was reacted 
with juglone, followed by subsequent treatment with Jones reagent, the desired 
anthraquinone was not achieved. Instead, the anthraquinone 35 was isolated. 
The Diels-Alder reaction was performed under varying conditions: boron 
trifluoride ethyl etherate and AICl3 as catalysts, as well as with no catalyst. The 
temperature and reaction times were altered; however, these variations only lead 
to different yields of the same anthraquinone 35. It was concluded that during 
the aromatization reaction expulsion of the trimethylsilyloxy ether occurred. This 
proved to be a major setback, since the hydroxyl group is essential for the 
closing of the pyranone ring to generate the full pluramycinone ring system. 
2. Synthesis of Anthraquinone 3 via a Procedure Based on O-
Methylkidamycinone 
As stated earlier, the potential existed to synthesize anthraquinone 3 by a 
procedure based upon the synthesis of O-methylkidamycinone (Scheme 4).3 If 
15 
successful, this procedure to generate 3 would prove to be a total of fifteen steps. 
The goal of this dissertation research was to develop methodology that could 
lead or would give a total synthesis of hydramycin that would be concise and 
convergent. This method lacked both; however, it was pursued as a last 
recourse concurrently with other methods (Scheme 7). 
By a sodium ethoxide-catalyzed condensation of ethyl acetoacetate and 
crotonaldehyde, intermediate 15 was generated. Without isolation, this 
intermediate was treated with HCI (g) to induce intramolecular cyclization into 
cyclohexanone 16. Addition of Br2 in HOAc and CCl4 was used to initiate 
aromatization of 16 into ethyl 2-hydroxy-6-methylbenzoate (18), which could be 
0-methylated with Me2S0 4. The resulting toluate 18, upon reaction with 3 
equivalents of LOA and 2.2 equivalents of phenyl disulfide yielded 19. This 
method, which was pursued through five steps, was aborted due to the length of 
the method and changes made during the dissertation research. 
3. Molten Salt Friedel-Crafts Reaction 
To avoid the troubles of the Diels-Alder reaction and the laborious 
process based upon 0-methylkidamycinone, the concept of constructing the 
anthraquinone ring system through a Friedel-Crafts reaction was adopted. 
Through the use of molten salt chemistry, the desired anthraquinone could 
possibly be synthesized. During the synthesis of some aminated 
naphthacenetriones, 30 the Friedel-Crafts coupling of phthalic anhydride to 2,3-
dimethylphenol was achieved by utilizing a molten mixture of AICl3 and NaCl. 
16 
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Scheme 7. Synthesis of Ethyl 2-(Bis-phenylsulfanylmethyl)-6-methoxybenzoate 
17 
Similar conditions were employed during studies of the herb Hedyotis diffusa31 
and synthetic strategies of kermesic acid32 and 4-
demethoxydaunomycinone33·34-all containing the anthraquinone moiety. The 
reaction conditions were extremely moisture sensitive, so care had to be taken 
during the experimental preparation. 
Initially, the hope was to perform a molten salt reaction on both phthalic 
anhydride and 3-hydroxyphthalic anhydride with 2,3-dimethylphenol to test the 
regiochemistry of the reaction (Scheme 8). If the desired anthraquinone 
regioisomers 36 and 37 were obtained, the 2,3-dimethylphenol could be replaced 
by one of several prepared aromatic derivatives (Scheme 9): 2-methoxy-6-
methylbenzaldehyde (38), 1-(2-methoxy-6-methylphenyl)ethanol (39) and 2-
methoxy-6-methylacetophenone (40). These derivatives could lead to or give the 
desired anthraquinone 3. 
Preparation of the aromatic derivatives began with 2,3-dimethylanisole. 
The peroxydisulfate ion (S2O8"2) is a tremendous oxidizing agent. 35 A 
regiospecific oxidation of 2,3-dimethylanisole to 2-methoxy-6-
methylbenzaldehyde (38) is possible when reacted with three equivalents of 
K2S2O8, along with copper sulfate, in a 1: 1 CH3CN-water mixture. 36 Reaction of 
38 with Meli yields 39, which can be easily oxidized to 40. While the correct 
anthraquinone regioisomers 36 and 37 were indeed obtained when 2,3-
dimethylphenol was used, the Friedel-Crafts coupling of the other aromatic 
derivatives was unsuccessful. This could be due to the electronic effects of the 
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Scheme 8. Test of Regioselectivity of Molten Salt Reaction 
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Scheme 9. Synthesis of 2-Methoxy-6-methylacetophenone 
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along with compounds 17 and 18. To further test the molten salt chemistry and 
the role of electronics on the reaction, other aromatics were synthesized for 
testing (Scheme 10). 
Through a Wittig reaction of 38 with n-Buli and 
methyltriphenylphosphonium bromide, it was possible to generate 3-methyl-2-
vinylanisole (41). 37 ·38 Sodium borohydride reduction of 38 led to (2-methoxy-6-
methylphenyl)methanol (42), which upon O-methylation with Me2SO4, generated 
2-methoxymethyl-3-methylanisole (43). Generation of 2-methoxy-6-
methylbenzoic acid (44) was achieved from the oxidation of 38 with NaCIO2 and 
H2O2•39 The m-cresol and 2,3-catechol reactions yielded the predicted 
anthraquinone products (1-hydroxy-3-methylanthraquinone and 1,2-dihydroxy-3-










successful in generating 1-hydroxy-3-methylanthraquinone-2-carboxylic acid 
(45), which upon subsequent reduction with LAH and selective oxidation yielded 
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Scheme 10. Synthesis of Aromatic Derivatives of 2-Methoxy-6-
methylbenzaldehye 
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Scheme 11. Synthesis of 1-Hydroxy-3-methylanthraquinone-2-carbaldehyde 
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1- hydroxy-3-methylanthraquinone-2-carbaldehyde (Scheme 11 ). 
Another attempt to generate anthraquinone 5 was tried by O-methylation 
of 36 with methyl iodide and K2CO3 to the corresponding methyl ether, 2,3-
dimethyl-1-methoxyanthraquinone (46). The 
selective oxidation procedure utilizing 
peroxysulfate ion was attempted on 46. From 
extensive experience with the reaction, it was 







success of the reaction. Since the solubility of 46 was quite low in a 1: 1 
CH3CN-water mixture, several approaches were tried to aid the reaction: the 
addition of a organic surfactant, addition of a trace amount of CH2Cl2 and/or 
toluene for solubility and the addition of pyridine, which promotes the oxidation in 
some cases. However, the oxidation did not occur and starting material was 
recovered. 
4. Overview 
From the strategies explored into the synthesis of appropriate 
anthraquinone ring systems, it was determined that the Friedel-Crafts chemistry 
offered the best possibility. From the synthesis of 1-hydroxy-3-
methylanthraquinone-2-carbaldehyde, an avenue to expand the methodology 
developed during the synthesis of the truncated analog to a compound with the 
anthraquinone ring system. The aldehyde anthraquinone was a potential lead 
into a synthesis of anthraquinones 3 and 5, which are needed for the coupling 
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strategies investigated: the aldol condensation and alkynyl coupling methods. 
B. Synthesis of Side Chain Synthons 
For the synthesis of the target molecule and hydramycin, there were two 
possible side chain synthons needed depending upon path a or path b of 
Scheme 1: one employed an aldehyde group and one used a terminal alkyne. 
While both groups are necessary for coupling to an aromatic moiety, the methods 
for coupling are very different. This chapter will delve into the chemistry behind 
the synthesis of aldehyde and alkyne side chain synthons. 
1. Aldehyde Side Chain Synthon 
Several approaches were envisioned for the aldehyde side chain synthon. 
The aldehyde group can be reacted with an acetyl group in an aldol condensation 
reaction, followed by elaboration into a pyranoanthraquinone. The principal 
difference in methods is whether the functionality is installed before or after the 
aldol chemistry. Specifics of the aldol coupling chemistry will be discussed 
shortly. 
a. Attempts to Generate a "Protected" Diene 
One possible method for installing the functionality was utilizing an 
aldehyde with olefinic groups that could be expanded via dihydroxylation and 
epoxidation. Using a reported synthesis40 of 2-acetyl-1,3-butadiene as a model, 
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a strategy for the preparation of 2-formyl-1,3-butadiene was formed (Scheme 







the strategy involves leaving the diene "trapped" and coupling it through aldol 
chemistry to the appropriate anthraquinone 3. 
In a Michael-type reaction of 2-mercaptoethanal, which is commercially 
available as the dimer (p-dithiane-2,5-diol), along with acrolein in the presence of 
Et3N, it is possible to generate the cyclic P-hydroxy compound 47. Compound 47 
can undergo catalyzed condensation forming 3-formyl-2,5-dihydrothiophene (48). 
As with the method of Belleau,40 the P-hydroxy compound can be reacted with 
DIPEA and MsCI to promote the unsaturation. However, it was observed that 
some unsaturated product formed even without the basic workup, so the 
reactivity of the hydroxy group must be high. Therefore by placing 48 in dry 
CH2Cl2, along with 4A Sieves and a catalytic amount of TFA, the condensation 
occurred with good yield without having to isolate 49. Unfortunately, the 
oxidation of 49 into the sulfone via m-CPBA proved to be problematic. The hope 
was that, once the compound is oxidized to the sulfone and coupled to the 
anthraquinone, thermal extrusion of sulfur dioxide (SO2) would generate the 
unprotected diene; however, the oxidation produced an inappreciable product. 
A concern that was present even before embarking on this strategy was the 
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Scheme 12. Strategy for a "Protected" Diene Side Chain Synthon 
25 
stability of the final aldehyde. The corresponding 2-acetyl-1,3-butadiene will 
dimerize into 1,4-diacetyl-4-vinyl-cyclohex-1-ene, but it can be reacted in situ.40 
Other 2-substituted-1,3-butadienes undergo similar dimerization. 41 •42 The 
proposed conclusion of the problem with the oxidation is that under the given 
conditions the SO2 will thermally eliminate before use causing dimerization and/or 
degradation. Reports of methods for making 2-acetyl-1,3-butadiene utilizing 
tricarbonyliron complexes are in the literature; 43 however, this route was not 
explored due to the finding that the aldehyde is unstable. 
b. Synthesis of lsopropylidene Glyceraldehyde 
Another possibility for an aldehyde side chain synthon was to have some 
of the functionality installed before coupling than install the remainder afterwards. 
The synthon would contain the hydroxyl groups before coupling to the aromatic 
portion (R), then subsequent deprotection and selective oxidation would give a 
keto compound that could be reacted with vinylmagnesium bromide than m-
CPBA. 
The hope was to incorporate 2,3-O-isopropylidenegylceraldehyde (50) 
onto the anthraquinone 3 through an Aldol condensation. Several methods for 
the preparation of 50 were explored (Scheme 13). Oxidation of 2,2-dimethyl-1,3-












aldehyde. It was reported that the oxidation of Solketal with PCC to generate 50 
was unsuccessful. 44 Therefore the oxidation of Solketal using Swem conditions 
was contemplated; however, it was discovered that the crude product cannot be 
fully purified. 44-46 This may be due to the fact that an aldehyde such as 50, that 
has an oxygen atom on the a-carbon can form a hydrated product, or a gem-diol, 
in the presence of water. Purification techniques cited for 50 after Swem 
oxidation, include distillation and silica gel column chromatography; however, 
when both were attempted during this research, the product degraded. Even 
when the crude product was subjected to silica gel TLC, the product spot had a 
lower R, value than the starting alcohol. This evidence verified the hydrate 
phenomenon. Because of the problems with purification, a process where there 
was little or no post reaction cleanup would be advantageous. 
The o-glyceraldehyde acetonide that is desired for the hydramycin project 
has been used as a chiral synthon in the synthesis of several biologically active 
compounds. 47 A synthetic strategy for the generation of 50 from inexpensive o-
mannitol, with no significant purification problems, was employed. A 
comprehensive study on various isopropylidene protection methods of o-mannitol 
reported the best method for the synthesis of 1,2:5,6-di-O-isopropylidene-o-
mannitol (51) was reacting o-mannitol with anhydrous zinc(II) chloride and dry 
acetone. 48 This generated the desired product and a trace amount of tri-
acetonide product. The desired 51 was purified by refluxing the product in a 
solution of 1 mUg of CHCl3 and 1 O mUg of petroleum ether for 30 min. 49 The 
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Scheme 13. Preparative Routes to lsopropylidene Glyceraldehyde 
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NalO4 in a 5% sodium bicarbonate media generates two equivalents of the 
needed aldehyde 50 with no purification. so.52 Aldehyde 50 was collected, 
dissolved in a precise amount of dry THF and stored over CaSO4 as a molar 
solution. The same cleavage can be achieved with lead tetraacetate [Pb(OAc)4] 
in ethyl acetate. 47 
c. Functionalized Side Chain Synthons 
While possibilities were explored for generation of a side chain synthon 
that could allow for functionality to be installed after coupling, the idea of 
delivering a fully functionalized side chain was also investigated. Still envisioning 
the use of an aldehyde for an Aldol coupling, the synthon 58, which would 
contain the needed hydroxyl groups, could be brought in with protected ethers 
and a vinyl group present for oxidation to the oxiranyl ring. An appropriate 
synthetic route was formulated (Scheme 14). 
Protection of Solketal with NaH and MEMCI to give the MEM ether, 
followed by deprotection of the O-isopropylidene group with 0.2 M HCI, would 
yield 3-(2-methoxyethoxymethoxy)-propane-1,2-diol (53). 53 Selective silylation of 
the primary hydroxyl of 53 with DMAP lends compound 54, which upon Swem 
oxidation gives the keto-compound, 1-(tert-butyldimethylsilyloxy)-3-(2-
methoxyethoxymethoxy)-propan-2-one (55). Reaction of 55 with 
vinylmagnesium bromide, then protection of the resulting alcohol 56 as the TBS 
ether, generates 3,4-bis-(tert-butyldimethylsilyloxy)-3-(2-
methoxyethoxymethoxymethyl)-but-1-ene (57). At this point, a problem arises. 
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Scheme 14. Proposed Route to Functionalized Side Chain Synthon 
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The hope is to deprotect the MEM ether in the presence of the silyl ethers, then 
oxidize to the aldehyde. When attempts were made to deprotect, either small 
amounts of starting material were recovered or the silyl ether was removed as 
well. Attempts were made with dimethylboron bromide,54 diphenylboron 
bromide 55 and dicyclohexylboron bromide. This problem led to the development 
of a route using a MPM ether instead. 
Since the MEM ether could not be successfully removed from 57, it was 
replaced with a MPM ether (Scheme 15). Protection of Solketal as the MPM 
ether could be achieved in a similar manner as above56•57 or with potassium tert-
butoxide generating 59. 58·59 With the addition of tetrabutylammonium iodide, the 
yield of the protection was increased. Use of a 1.0 M solution of HCI facilitated 
the deprotection of the O-isopropylidene group in 59, yielding diol 60. 60 The 
stronger acid gave a better yield then the 0.2 M solution used previously. 
Selective silylation gave compound 61; however, the Aldol chemistry was 
abandoned, so progress on the scheme was stopped. 
2. Synthesis of Alkyne Side Chain Synthon 
A synthesis for an appropriately functionalized alkyne was developed 
(Scheme 16). Generation of benzyloxyacetic acid (63) was achieved by the 
reaction of sodium benzyloxide with the sodium salt of chloroacetic acid. 
Reaction of acid 63 with COi and N,O-dimethylhydroxylamine hydrochloride 
yielded amide 64.61·62 The use of N-methoxy-N-methylamides, also known as 
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Scheme 16. Synthesis of Alkyne Synthon: 3-Benxyloxymethyl-
pent-1-en-4-yn-3-ol 
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controlling the addition of organometallic reagents through a metal-chelated 
intermediate. Therefore, when amide 64 was reacted with excess lithium 
trimethylsilylacetylide, keto-compound 65 was isolated, not the disubstituted 
product. Further elaboration of 65 with vinylmagnesium bromide gave tertiary 
alcohol 66, which upon desilylation with a catalytic amount of sodium methoxide 
in methanol, furnished 3-benzyloxymethyl-pent-1-en-4-yn-3-ol (67)-the target 
alkyne. 
3. Overview 
During the experimental trials for finding an appropriate aldehyde and 
alkynyl side chain synthon, it appears that use of aldehyde 50 and alkyne 67 will 
give the best chance for coupling. Aldehyde 50 could be coupled in an Aldol 
condensation reaction and cyclized, then further elaborated into the necessary 
functionality. Alkyne 67 could be coupled to an appropriate aldehyde with the 
functionality already installed. 
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C. Coupling Techniques 
1. Attempts to Generate the Pyranone Ring System through Aldol 
Condensation Chemistry 
To test the plausibility of coupling aldehyde 4 to anthraquinone 3 using 
aldol chemistry (Scheme 1, path a), a model study was developed. By replacing 
the anthraquinone ring system with various compounds consisting of a single 
aromatic ring, it would be possible to create an analog similar in structure to 
hydramycin. The aromatic analogs would contain the pyranone moiety and a 
group that could be used to generate the necessary functionality of hydramycin. 
The aromatic compound would need to have a hydroxyl or protected hydroxyl 
group at C 1 and an acetyl group at C2 to mimic anthraquinone 3 (Scheme 17). 
By protecting the hydroxyl group of commercially available 2'-
hydroxyacetophenone as the terl-butyldimethylsilylether, it was possible to 
generate 2-(terl-butyldimethylsilyloxy)acetophenone (68). 0-Demethylation of 40 
with boron tribromide yielded 2-hydroxy-6-methylacetophenone (69), which upon 
silylation gave acetophenone (70). These aromatics were used during the the 
procedures developed during the aldol condensation model study. 
Initially, the model study involved the aldol condensation of p-
anisaldehyde and 2'-hydroxyacetophenone, followed by Se0 2-induced cyclization 
of the a, P-unsaturated ketone into the pryanone ring system (Scheme 18). 3 
Reacting the enolate of 2'-hydroxyacetophenone, generated by LOA, with p-
anisaldehyde gave P-hydroxy keto-compound 71. Several methods for the 
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Scheme 18. Synthesis of 2-( 4-Methoxyphenyl)-chromen-4-one 
36 
dehydration of 71 were explored; however, the use of a weakly acidic cation 
exchange resin (Amberlite CG-50) in methanol afforded the a,P-unsaturated 
compound 72 in the best yield. Upon cyclization with SeO2, the pyranone system 
was formed generating compound 73. Since these conditions yielded the 
desired cyclized product, the model study was expanded to determine if the use 
of 50 would yield similar results. 
OH 0 OHO OH 
(YMe + LDA 
THF 
74 
From the initial results of the model study, it appeared that reaction of the 
enolate of 2'-hydroxyacetophenone and 50 could give the needed P-hydroxy keto 
compound 7 4; however, it was found that the use of acetophenoe 68 gave a 
better yield. Therefore, to generate the new model target-2-(2,2-dimethyl-
[1,3]dioxolan-4-yl)-chromen-4-one (78)-the aldol condensation of the lithium 
enolate of 68 and 50 was explored (Scheme 19). There was some concern over 
the conditions of the dehydration due to the instability of the O-isopropylidene 
group, so it was determined that the intermediate P-hydroxy keto-compound 75 
would not be isolated during the procedure, and the dehydration conditions would 
be altered to the use of MsCI and Et3N. Desilyation of 76 with TBAF generated 
phenolic 77, which upon SeO2 cyclization gave the model study target as a crude 
product. However, the yields of both the condensation and cyclization were 
extremely low, and isolation and purification were difficult. The conditions of the 
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Scheme 19. Synthesis of 2-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-chromen-4-one 
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dehydration are varied to try to increase the yield, but to no avail. 
Even though the chemistry behind the aldol condensation method for the 
formation of the pryanone ring system in the model study was successful, the 
yields in the actual system were too low to allow for further use. Along with the 
problems of synthesizing an appropriate aldehyde, these low yields led to the 
discarding of the aldol strategy and developing of the alkynyl coupling strategy 
(Scheme 1, path b). 
2. Alkynyl Coupling and Cyclization for Pyranone Synthesis 
A strategy developed for generating the pyranone ring system of 
hydramycin involved the coupling of an appropriate benzaldehyde to an alkynyl 
side chain synthon (Scheme 5). Through deprotonation of the alkyne, it was 
possible to consider a nucleophilic attack of the alkyne on the carbonyl of the 
derivatized benzaldehyde. The resulting alcohol could be oxidized, leaving an 
ethynyl ketone that could be cyclized into the needed pyranone via fluoride-
induced 6-endo-digonal ring closure.1·s.a Once the pyranone ring was formed, the 
necessary functionality could be installed through the alkyne. 
As with the aldol condensation chemistry, a model study was developed 
that replaced the anthraquinone system (5) with a benzaldehyde derivative, 
which consisted of an ortho silyl ether necessary for the ring closure. Therefore, 
the synthesis of both 2-(terl-butyldimethylsilyloxy)benzaldehyde (79) and 2-(terl-
butyldimethylsilyloxy)-6-methylbenzaldehyde (81) were needed (Scheme 20). 
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Scheme 20. Synthesis of Derivatized Benzaldehydes 
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achieved with the use of TBSCI. Compound 80, from the 0-demethylation of 38, 
was protected under similar conditions giving benzaldehyde 81. 
To test the procedure for the coupling, the strategy was employed on 81 
and commercially available 3-methyl-1-penten-4-yn-3-ol. The dianion generated 
from the reaction of the alkyne with two equivalents of MeMgBr was reacted with 
benzaldehyde 81. The more nucleophilic carbanion reacted with the carbonyl of 
OH TBSO OH 




the benzaldehyde generating 1-[2-(tert-butyldimethylsilyloxy)-6-methylphenyl]-4-
methylhex-5-en-2-yne-1 ,4-diol (82) in good yield. Since the methodology 
seemed sound, the strategy was adapted to coupling 81 and the needed alkyne 
67. To generate the dianion, two possibilities were explored: both MeMgBr and 
n-Buli were each used to remove the hydroxyl and alkynyl protons. It was 
determined that the grignard reaction gave a higher yield; therefore, when the 
dianion of 67 was reacted with 81 in route to the desired hydramycin analog 1 
(Scheme 21 ), the dial 83 was obtained. Oxidation of the resulting alcohol was 
performed with activated Mn0 2 giving ethynyl ketone 84. After fluoride-induced 
cyclization and epoxidation of the free olefin with m-CPBA gave epoxide 86. 0-
Debenzylation of 86 was achieved through hydrogenation using palladium-on-
carbon in ethyl acetate to avoid saturation of the pyranone ring. The resultant 
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Scheme 21. Synthesis of 2-(1,2-Dihydroxy-1-oxiranylethyl)-
5-methylchromen-4-one 
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product was the truncated analog 1. The yield of the epoxidation was low, so it 
was thought that performing the epoxidation first before coupling might"raise the 
yield. Since the epoxide ring would be susceptible to attack by the MeMgBr, it 
would be necessary to use n-Buli for deprotonation of the alkyne. The strategy 










m-CPBA. The dianion of alkyne 87, prepared from n-Buli, was coupled to 81 to 
synthesize dial 88. Even though the epoxidation yield was higher, the coupling 
technique with n-Buli gave a poor yield. Hence, the procedure outlined in 
Scheme 21 was complete and the synthesis of analog 1 was finished. 
3. Coupling of Alkyne with N-Methoxy-N-methyl Derivatives 
An alternative method of coupling the aldehyde was generated near the 
conclusion of Scheme 21. The yield for the oxidation of 83 was moderate, so a 
strategy that might avoid this step was developed. If the N-methoxy-N-methyl 
amide derivative of the aldehyde could be synthesized, the alkyne could be 
coupled yielding the necessary keto-compound. If successful, this strategy could 
be employed to anthraquinone acid 45. 
Two unique methods for generating the Weinreb amide was tried: the 
previously stated method with COi (method A) and a method utilizing CBr4, PPh3, 
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pyridine and N,O-dimethylhydroxylamine hydrochloride (method 8).64 Several 
benzoic acid derivatives were used to test both methods: salicylic acid, o-anisic 
acid, previously discussed acid 44, and 2-(tert-butyldimethylsilyloxy)benzoic acid 
(89)-synthesized from the silylation of salicylic acid. Reaction of o-anisic acid 
under the conditions of method B gave a poor yield of amide 90, while no other 
reactions gave the appropriate amiode product (Scheme 22). Both methods 
were performed on anthraquinone 45 with no resulting product. 
To determine if it was worth pursuing this strategy, amide 90 was reacted 
with the bromomagnesium salt of alkyne 67. This reaction gave no coupling 
product and the amide was not recovered, therefore the idea of generating a N-
methoxy-N-methyl derivatives for coupling was discarded. 
4. Overview 
The synthesis of analog 1 was important to establish a successful 
synthetic scheme capable of installation of the proper functionality and the 
pyranone ring found in 2. Using the synthesized aldehyde anthraquinone, a 
synthesis of 2 could be realized. The antibiotic and antitumor activity of analog 1 
is predicted to be negligible, since reports have indicated that the minimal 
structural requirement for efficacy of pyranoanthraquinones is the ABC ring 
system. 8 However, the synthetic methodology developed during the synthesis of 
1 could be expanded to include the full anthraquinone ring moiety yielding 2 and 
possibly other pluramycinones. 
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Scheme 22. Reactions during the N-Methoxy-N-methyl Derivative Study 
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D. Conclusions and Future Work 
The research goal of realizing a viable synthetic strategy for 1 was a 
success. Through the use of an innovative alkyne synthesis, a fluoride-induced 
ring closure and creative synthetic strategies, it was possible to generate a 
compound whose functionality mimics that of hydramcyin. While the failures and 
complications that arose throughout the research where many, they were 
instrumental in its development. 
The molten salt chemistry generated yielded the aldehyde anthraquinone 
(1-hydroxy-3-methylanthraquinone-2-carbaldehyde), which gives a platform to 
expand the methodology of this dissertation into an analog of hydramycin that 
contains the full anthraquinone ring system and pluramycinone 2 itself. However, 
there exists other alternative methods for generating the same aldehyde 
anthraquinone that may prove to be more effective. The potential for producing 




A. General Experimental Protocol 
Proton (1 H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were acquired on either a Bruker WP250 (250.13 and 62.89 MHz, 
respectively) or Varian Mercury 300 (300.09 and 75.46 MHz, respectively) 
instruments. When CDCl3 was used as the NMR solvent, the reported chemical 
shifts for the 1H NMR spectra are given in~ units, which represents parts per 
million (ppm) downfield from the peak from the added standard TMS found at c5 
0.0. Reported chemical shifts for 13C NMR spectra are in relation to the solvent 
triplet found at~ 77.0 in CDCl3. Unless otherwise indicated, the solvent for NMR 
spectra was CDCl 3. Spin-spin splitting patterns are abbreviated as follows: s = 
singlet, br s = broad singlet, d = doublet, t = triplet, dd = doublet of doublets, ddt 
= doublet of doublet of triplets and m = multiplet. 
Melting points were determined in open capillary tubes on a 
Thomas-Hoover Uni-melt melting point apparatus and reported in °C, 
uncorrected. IR spectra were obtained on a Bomem MB-Series spectrometer as 
neat liquids or KBr pellets. Elemental analyses were furnished by Atlantic 
Microlab Inc., Norcross, GA and are within ±0.4% of the theoretical values. 
Electron-impact mass spectra (EIMS) were obtained on a VG-ZAB-EQ mass 
spectrometer (Manchester, England) using an ionization potential of 70 eV. 
Boiling points were determined during distillation and are reported as °C. 
Column chromatography and TLC were performed with E. Merck Silica Gel 60 
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products: aluminum-backed plates impregnated_with fluorescent indicator F254 for 
TLC, and 4~3 µm mesh silica gel for column chromatography. The solvent 
used for the development of the plates or elution of the column is indicated for 
the specific reaction in the experimental section. The detection of the component 
spots was accomplished with uv illumination at 254 nm, spray-heat p-
anisaldehyde dip, and/or iodine chamber development. The pH of a solution was 
determined by color comparison on pH Hydrion Paper or via a pH meter. 
THF was distilled and collected for immediate use from 
sodium-benzophenone ketyl. Anhydrous CH2Cl2 , anhydrous DMSO, anhydrous 
toluene and anhydrous hexane were dried and distilled from CaH2, then collected 
for immediate use. DMF was distilled at reduced pressure from CaH2 , then 
collected and stored over 4 A Sieves. Et3N used as a reagent was dried over 
CaH2, distilled, collected and stored over NaOH pellets. Reagent grade acetone 
was dried and stored over CaSO4. NaH, as a 60% oil dispersion, was washed 
with several aliquots of hexane, then immediately covered by dry reaction 
solvent. Anhydrous zinc(II) chloride was generated by extreme heating of 
hydrated zinc chloride until all moisture was removed. The commercially 
available 57-86% pure m-CPBA was washed with an aqueous pH 7.5 phosphate 
solution for 20 min, filtered and collected, then dried on a vacuum pump for 24 h. 
Nitrogen gas, used in a positive-pressure nitrogen line for reactions, was pre-
dried via two separate drying tubes before use. All other chemicals used 
throughout the research were of commercial reagent grade, and unless 
otherwise noted, were not purified further. 
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After all extractions, the organic layer was dried with either Na2SO4 or 
MgSO4 and filtered. In general, if the organic solvent was more dense than 
water, Na2SO4 was used; however, if the organic layer was less dense than 
water MgSO4 was used. After allowing the drying agent and the organic layer to 
stand for 2-5 min, the mixture was filtered by vacuum filtration to remove the 
drying agent. 
Several ion-exchange resins were used throughout this dissertation. The 
resin was first swelled in a 1: 1 mixture of methanol-water for 1 h, then filtered. 
The resin was charged by being subjected to either an acidic (1.0 M HCI) or 
basic (1.0 M NaOH) wash, depending on the resin. After the appropriate wash, 
the resin was washed thoroughly with water until pH paper indicated the rinse 
solution was neutral. The resin was finally washed and stored in methanol, so 
that it could be used in an organic media. Amberlite A-21 is a weakly basic ion-
exchange resin, Amberlite IRA-400 is a quaternary ammonium strongly basic 
resin and Amberlite CG-50 is a weakly acidic carboxylic acid resin. 
Several cold-temperature baths were used throughout this research. The 
temperatures were achieved by the following means: 0 °C bath achieved with ice 
and water, -1 O °C bath achieved with ice, NaCl and water, -15 °C bath achieved 
with ice and acetone, -50 °C bath achieved with solid carbon dioxide (dry ice) 
and CH3CN, and -78 °C bath achieved with dry ice and acetone. All other 
variable cold baths were achieved by close monitoring of addition of dry ice to 
acetone by low-temperature thermometer. Heating devices used include both a 
heating mantle and a silicon oil bath connected through a variable transformer. 
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B. Friedel-Crafts Coupling in a Molten Salt Mixture of AICl3 and NaCl. 
It is possible to conduct a Friedel-Crafts coupling reaction of an aromatic 
anhydride and an appropriate aromatic compound using a AICl3-NaCI molten salt 
reaction. 30•31•65 The aromatic species can be either a solid or non-solid (oily) 
reagent; however, different experimental methods are needed for each 
(discussed below). For both methods, the most important issue is eliminating 
moisture throughout the entire apparatus. Therefore, all glassware was oven 
dried and stored in a desiccator filled with CaSO4, and all nitrogen lines were 
fitted with drying tubes filled with CaSO4. The NaCl was pre-dried in a vacuum 
oven at 150 °C/0.5 torr. The AICl3 was weighed under inert atmosphere 
conditions in a three-neck reaction flask, then quickly flushed with excess 
nitrogen. Aromatic reagents were placed on vacuum line for 10-12 h to eliminate 
any moisture. 
1. General Procedure for a Coupling of an Anhydride with a Non-solid 
Aromatic Reagent 
The NaCl and AICl3 were placed in a three-neck flask fitted with a 
magnetic stirbar, a drying tube, a rubber septum and a solid addition funnel. The 
anhydride was ground with a mortar and pestle, then placed in the funnel, which 
was fitted with a gas line providing a continuous flow of dry nitrogen through the 
system and out the drying tube. The flask was placed in an oil bath and heated 
to the appropriate temperature; each reaction was found to have a unique 
reaction temperature, which is specified in the individual experimental section for 
50 
the reaction. At approximately 120 °c, the AICl3-NaCI mixture melted into a gray 
slurry, which at 140 °C turned into a gray liquid. Once the appropriate 
temperature was reached, the anhydride was added. After 5 min, the non-solid 
aromatic reagent was injected via syringe through the septum. During the 
addition of the non-solid aromatic reagent, the reaction mixture turned a dark 
maroon-black color, and copious amounts of HCI (g) was generated. The gas 
was flushed out of the system through the drying tube. For safety reasons, the 
drying tube can be fitted with a gas line that carries the HCI (g) to a cold-water 
trap. After all reagents were added, the mixture was allowed to stand for 10-15-
min. At this point, the oil bath was removed to cool the reaction. When the 
mixture began to thicken at 115 °C, ice was added to quench the reaction, 
followed by the appropriate amount of cone HCI. After the mixture was filtered, 
and the solid was extracted with 1,2-dichloroethane in a Soxhlet extraction 
apparatus for 24-48 h. 66 The extraction solution was filtered to remove the 
boiling chips. The solvent was evaporated, yielding a residue, which was passed 
through a silica gel column with CH2Cl2_ The crude solid was crystallized and/or 
subjected to column chromatography with the appropriate solvent system and 
analyzed. 
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2. General Procedure for Coupling of an Anhydride with a Solid Aromatic 
Reagent 
The NaCl and AICl3 were placed in a three-neck round bottom flask, which 
was fitted with a magnetic stirbar, a drying tube and two solid addition funnels. 
The pre-ground anhydride and the solid aromatic reagent were each placed into 
a solid addition funnel. One of the solid addition funnels was fitted a gas line 
providing a continuous flow of dry nitrogen through the system and out the drying 
tube. The flask was placed in an oil bath and heated to the appropriate 
temperature; each reaction was found to have a unique temperature, which is 
specified in the individual experimental section. At 120 °C, the AICl3-NaCI 
mixture began to melt into a gray slurry and at 140 °C turned into a clear gray 
liquid. Once the appropriate temperature was reached, the anhydride reagent 
was added slowly. After 5 min, the second aromatic reagent was added, and the 
reaction mixture immediately turned a dark maroon color with the release of 
copious amounts of HCI (g), which was flushed out of the system through the 
drying tube. For safety reasons, it is possible to replace the drying tube with a 
gas line which passes through a drying tube into a cold water trap for the 
escaping HCI (g). Once all reagents were added, the reaction mixture was 
allowed to stand for 5--20-min (the individual times will be specified in individual 
sections). The oil bath was removed and the reaction mixture cooled. As the 
mixture cooled, it began to thicken at 115 °C. At this point, ice was added to the 
quench the reaction, followed by addition of cone HCI. The mixture was filtered, 
and the solid was collected and extracted with 1,2-dichloroethane in a Soxhlet 
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extraction apparatus for 24-48-h. 66 The extraction solution was filtered to 
remove the boiling chips and evaporated, yielding the crude product. The 
·· product was chromtaographed over a silica gel column with CH2Cl2. The product 
was crystallized and/or subjected to column chromatography with the appropriate 
solvent system and analyzed. 
C. Experimental Procedures 
1. Anthraquinone Synthon Synthesis 
Preparation of 2-Bromo-3-methyl-2-butenal (30). 
Approximately 100 ml of CH3CN was placed in a 250-ml round-bottom 
flask, fitted with a magnetic stir bar, and cooled to -30 °C. The flask was fitted a 
rubber septum and a nitrogen-filled balloon. To the stirred solution, 10.0 ml 
(136.2 mmol) of dimethyl sulfide was injected, followed by 6.5 ml (126.2 mmol) 
of Br2• After 15 min, a solution of 12.6 ml (130.6 mmol) of 3-methyl-2-butenal 
dissolved in 1 0 ml of CH3CN was added to the bromodimethylsulfonium 
bromide, 27 which remained in situ, forming deep-yellow crystals. When the 
reaction mixture was warmed to -20 °C, the crystals disappeared, and at -18 °C 
light-yellow crystals precipitated out, at which time the septum was removed and 
100 ml of ethyl ether was added to the solution. The precipitate was collected 
and washed with additional ether. The solid was dissolved in 250 ml of distilled 
water containing 13.2 g of NaHCO3. After heating in a 35 °C water bath, the 
solution was extracted with CH2Cl2, dried and concentrated to yield 15.6 g (76%) 
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of 30; bp 66 °C/15 torr (lit.29 68°C/15 torr). 1H NMR (250 MHz, CDCl3) 6 2.22 (s, 
3H), 2.38 (s, 3H), 9.74 (s, 1 H). 13C NMR (63 MHz, CDCl3) 6 21.36, 26.07, 
122.98, 156.36, 162.71. 
Preparation of 2-Bromo-3-methyl-1-trimethylsilyloxy-1,3-butadiene (31 ). 
In a 250-ml two-neck round-bottom flask, fitted with a condenser, a 
rubber septum and a magnetic stir bar, 0.32 g (2.3 mmol) of anhydrous zinc(II) 
chloride was placed in 50 ml of anhydrous toluene. The flask was placed in an 
oil bath and fitted with a positive-pressure nitrogen line. To the stirred solution, 
13.6 g (83.2 mmol) of 2-bromo-3-methyl-2-butenal was injected. After 10 min., 
13.0 ml (102.4 mmol) of TMSCI was injected, followed by a slow injection of 22.0 
ml (157.8 mmol) of Et3N. The reaction was heated to 65 °c for 3 h, then 80 °C 
for 30 min. To the formed precipitate, 90 ml of distilled hexane was added and 
the heat was removed. The solution was filtered, concentrated by evaporation 
and distilled, yielding 10.2 g (52%) of 31; bp 58 °C/1 torr (lit.28 69-71 °C/3 torr); 1H 
NMR (250 MHz, CDCl3) 6 0.27 (s, 9H), 1.97 (s, 3H), 4.95 (s, 1 H), 5.34 (s, 1 H), 
6.82 (s, 1H). 13C NMR (63 MHz, CDCl3) 6-0.36, 20.57, 110.68, 115.18, 137.92, 
138.80. 
Generation of Jones Oxidation Reagent 
A solution of 7.915 g (7.9 mmol) of chromium(VI) oxide dissolved in 14.8 
ml of distilled water was placed in a 250-ml round-bottom flask and cooled to O 
54 
°C. As the solution was vigorously stirred, 6.9 ml of concentrated H2SO4 was 
slowly added. The reagent was stored at O 0 c. 
Synthesis of 7-bromo-1-hydroxy-6-methylanthraquinone (35). 
A solution of 0.91 g (5.2 mmol) of 5-hydroxy-1,4-naphthaquinone 
dissolved in 50 ml of anhydrous toluene was placed in a 100-ml round-bottom 
flask under nitrogen. Once the flask was cooled to -78 °C, 0.15 ml (1.2 mmol) of 
boron trifluoride ethyl etherate was added.26 After 10 min, a solution of 2.06 g 
(8.8 mmol) of 31 dissolved in 10 ml of anhydrous toluene was added dropwise 
via syringe. The solution was stirred at -78 °C for 4 h, then allowed to warm to 
RT over 24 h. The solvent was removed under vacuum, and to the crude organic 
residue was added 10 ml of acetone and 0.5 ml of Jones oxidation reagent. 
After stirring for 30 min, the reaction was quenched with 2-propanol and 
evaporated. The organic residue was subjected to silica gel column 
chromatography (6:1 hexane-ethyl acetate), yielding 1.32 g (75.7%) of 35. 1H 
NMR (300 MHz, CDCl3) 6 2.59 (s, 3H), 7.32 (d, 1 H), 7.69 (dd, 1 H), 7.81 (d, 1 H), 
8.13 (s, 1 H), 8.45 (s, 1 H), 12.50 (s, 1 H). 13C NMR (75 MHz, CDCl3) 6 22.63, 
119.69, 124.58, 128.87, 129.42, 130.95, 131.49, 132.03, 132.15, 132.27, 133.33, 
136.92, 145.89, 162.59, 182.08. 
Alternate methods using anhydrous CH2Cl/ 4, no Lewis acid catalyst and 
AICl3 as a Lewis acid catalyst25 all led to the same product in varying (lower) 
yields. 
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Preparation of Ethyl 6-Methyl-2-oxocyclohex-3-enecarboxylate (16). 
To a solution of 0.8 g (34.8 mmol) of sodium metal dissolved in 350 ml of 
anhydrous ethanol was slowly added 95.0 ml (0.75 mol) of ethyl acetoacetate. 
The reaction mixture was cooled to O °C, and a solution of 63 ml (0. 76 mol) of 
crotonaldehyde dissolved in 80 ml of anhydrous ethanol was added over 1 h. 
The mixture was allowed to warm to RT and stir for 24 h, during which time the 
solution became cloudy and yellow. The mixture was again cooled to O °C and 
saturated with anhydrous HCI (g). A CaSO4 trap was placed between the HCI (g) 
source and the reaction vessel to ensure that the gas was dry. After saturation, 
the reaction mixture was allowed to stir at RT for 25 h. Using NMR 
spectroscopy, it was possible to follow the disappearance of the acetyl peak of 
the intermediate at c5 = 2.2 ppm. 67 If the peak persisted, the reaction mixture was 
resaturated with dry HCI (g) and allowed to stir for 1 h. Once the monitoring 
process showed the acetyl peak was gone, the solution was concentrated, and 
the product was vacuum distilled. At 55 °C/0.5 torr, some decomposition 
occurred (as seen by a rise in pressure) and persisted for 45 min. After the 
pressure returned to 0.5 torr, the collection flask was replaced, and 77.9 g 
(57.0%) of 16 was collected; bp. 92 °C/0.5 torr (lit.67 80-95 °C/0.5 torr; lit.68 90 
°C/0.2 torr). 
Preparation of Ethyl 2-Hydroxy-6-methylbenzoate (17). 
A solution of 77.9 g (0.43 mol) of cyclohexanone 16 dissolved in 150 ml 
of CCI4 was placed in a 1-l three-neck round-bottom flask fitted with an addition 
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funnel and two condensers. The condensers were used to control the copious 
amounts of HBr (g) generated. A continuous flow of nitrogen was brought in 
through one condenser and out the other into a water trap. The flask was cooled 
to O °C, and a mixture of 23 ml (0.45 mol) of Br2 in 11 O ml of HOAc was added 
in a steady stream. After the addition funnel was replaced with a stopper, the 
reaction was heated to reflux for 18 h. The solution was cooled to RT and diluted 
with 300 ml of CH2Cl2 and 300 ml of water. The organic layer was washed with 
a saturated solution of NaHCO3 followed by water, then dried, evaporated and 
steam distilled. The product co-distilled at 102 °C, as white crystals (caution had 
to be taken, since product would precipitate out in the condenser). After 
crystallization in methanol-water, the reaction yielded 20.4 g (26.5%) of 17 as 
white crystals, mp 39-40 °C (lit.67 42 °C; lit.68 42.5 °C). 1H NMR (300 MHz, 
CDCl3) 6 1.43 (t, 3H), 2.55 (s, 3H), 4.43 (q, 2H), 6.71 (d, 1 H), 6.84 (d, 1 H), 7.27 
(dd, 1 H), 11.39 (s, 1 H). 13C NMR (75 MHz, CDCl3) 6 14.05, 24.03, 62.17, 
115.49, 122.81, 134.01, 137.08, 138.90, 158.91, 167.18. 
Preparation of Ethyl 2-Methoxy-6-methylbenzoate (18). 
A stirred solution of 20.3 g (113 mmol) of phenol 17, 29.4 g (213 mmol) of 
anhydrous K2CO3 and 14.5 ml (153 mmol) of Me2SO4 in 500 ml of anhydrous 
acetone was refluxed for 7 h. The reaction was monitored by silica gel TLC 
(CH2Cl2). The solution was filtered, evaporated and dissolved in 700 ml of ethyl 
ether, and Et3N was added to remove any residual dimethyl sulfate. The organic 
solution was thoroughly washed with three portions each of the following: water, 
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0.1 M HCI, and a saturated solution of NaCl. The organic layer was dried, 
evaporated and distilled, yielding 15.8 g (72.0%) of 18, bp 89-90 °C/0.8 torr (lit.67 
89-91 °C/1 torr). 1H NMR (300 MHz, CDCl3) 6 1.38 (t, 3H), 2.30 (s, 3H), 3.81 (s, 
3H), 4.39 (q, 2H), 6.75 (d, 1 H), 6,80 (d, 1 H), 7.23 (dd, 1 H). 13C NMR (75 MHz, 
CDCl 3) 6 14.07, 18.89, 55.61, 60.86, 108.27, 115.37, 122.14, 129.97, 133.90, 
136.02, 168.14. 
Preparation of Ethyl 2-{Bis-phenylsulfanylmethyl)-6-methoxybenzoate (19). 
A 100-ml round-bottom flask, fitted with a positive-pressure nitrogen line 
and cooled to -78 °C, was filled with 15 ml of anhydrous THF and charged with 
8.0 ml of a 2.0 M solution of LOA. A solution of 1.22 g (6.3 mmol) of toluate 18 
dissolved in 15 ml of anhydrous THF was added via syringe. To the reddish-
orange anionic solution was rapidly added a solution of 2.68 g (12.3 mmol) of 
phenyl disulfide in 15 ml of anhydrous THF. Once the reaction warmed to RT, 
the reaction was quenched with 10 ml of HOAc and 30 ml of water. The 
organic layer was evaporated to an oil and dissolved in ethyl acetate, then 
washed with water, a 5% solution of NaOH, and a saturated solution of NaCl. 
The organic layer was dried, evaporated and subjected to silica gel column 
chromatography (3:1 hexane-CH 2Cl2), yielding 0.73 g (28.3%) of 19, mp 73-75 
°C (lit.69 75-76 °C). 1H NMR (300 MHz, CDCl3) 6 1.25 (t, 3H), 3.80 (s, 3H), 4.28 
(q, 2H), 5.70 (s, 1 H), 6.81 (d, 1 H), 7.21-7.37 (m, 12H). 
58 
Synthesis of 1-Hydroxy-2,3-dimethylanthraguinone (36). 
Following the method outlined in 82, 4.91 g (84.0 mmol) of dry NaCl and 
22.02 g (165.1 mmol) of AICl3 were placed in the reaction system. A pre-ground 
sample of both 3.13 g (21.1 mmol) of phthalic anhydride and 2.63 g (21.5 mmol) 
of 2,3-dimethylphenol were placed in the two addition funnels. The system was 
heated to 175 °C, and the first solid reagent (anhydride) was slowly added. After 
5 min, the second reagent was added. After reacting for an additional 1 0 min, 30 
the system was allowed to cool until the reaction mixture began to thicken at 115 
°C. At this point, 50 g of ice and 25 ml of concentrated HCI was added. The 
solid was filtered and extracted. The extraction solution was evaporated and 
subjected to silica gel column chromatography (CH2Cl2). The crude product was 
crystallized with CH2Cl2--ethyl ether, yielding 2.15 g (40.3%) of 36 as orange 
crystals; mp 219.5-220.5 °C (lit.70 220-221.5 °C; lit.30 213-215 °C). 1H NMR 
(300 MHz, CDCl 3) ~ 2.30 (s, 3H), 2.43 (s, 3H), 7.66--8.31 (m, SH), 13.04 (s, 1 H). 
13C NMR (75 MHz, CDCl3) ~ 12.04, 21.23, 121.44, 127.04, 127.49, 130.46, 
133.20, 133,67, 133.99, 134.19, 134.59, 139.41, 146.83, 161.17, 183.00, 188.69. 
Anal. Calcd for C16H12O3 : C, 76.18; H, 4.79 Found: C, 75.88; H, 4.83. 
Synthesis of 2,3-Dimethyl-1-methoxyanthraquinone {46). 
A solution of 0.303 g (1.2 mmol) of 36 dissolved in 125 ml of acetone was 
placed in a 250-ml round-bottom flask along with a magnetic sitrbar. After 0.67 4 
g (4.8 mmol) of K2CO3 and 0.30 ml (4.8 mmol) of Mel was added, the flask was 
fitted with a condenser and placed in a heating mantle. The mixture was refluxed 
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for 1 0 h while being monitored by TLC (CH2Cl2). After the mixture was cooled, 
the solvent was evaporated, and the residue was extracted with CH2Cl2 and 
sequentially washed with water, a saturated NH4CI solution and a saturated NaCl 
solution. The organic layers were collected, dried, evaporated, and subjected to 
silica gel column chromatography (CH2Cl2), which allowed the isolation of orange 
needle-shaped crystals. These collected crystals were crystallized from 
CH2Cl2-ethyl ether yielding 0.30 g (93.0%) of 46; mp 166.5--167.5 °C (lit.30 
165--167 °C). 1H NMR (300 MHz, CDCl3) ~ 2.34 (s, 3H), 2.43 (s, 3H), 3.90 (s, 
3H), 7. 73-8.28 (m, SH). 13C NMR (75 MHz, CDCl3 ) ~ 12.62, 21.02, 61.18, 
123.49, 124.69, 126.55, 127.12, 132.58, 132.69, 133.30, 134.05, 134.85, 139.57, 
145.48, 158.82, 182.46, 183.43. Anal. Calcd for C17H140 3: C, 76.68; H, 5.30 
Found: C, 76.54; H, 5.19. 
Synthesis of 1,8-Dihydroxy-2,3-dimethylanthraquinone (37). 
Following the method outlined in 82, 1.28 g (21.9 mmol) of dry NaCl and 
7.80 g (58.5 mmol) of AICl3 were placed in the reaction system. A pre-ground 
sample of both 1.06 g (6.5 mmol) of 3-hydroxyphthalic anhydride and 0.80 g (6.6 
mmol) of 2,3-dimethylphenol were placed in the two addition funnels. The 
system was heated to 210 °C, and the first solid reagent (anhydride) was added. 
After 5 min, the second reagent was added. After reacting for an additional 1 O 
min, the system was allowed to cool until the reaction mixture began to thicken at 
119 °C. At this point, 45 g of ice and 25 ml of cone HCI was added. The solid 
was filtered and extracted. The extraction solution was evaporated and run 
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through a silica gel column (CH2Cl2). The crude product was crystallized from 
CH2Cl2-ethyl ether, yielding 0.09 g (5.0%) of 37 as dark-orange crystals. 1H 
NMR (300 MHz, CDCl3) 0 2.30 (s, 3H), 2.44 (s, 3H), 7.28-7.85 (m, 4H), 12.74 (s, 
1H), 13.07 (s, 1H). 13C NMR (75 MHz, CDCl3) 0 21.07, 60.41, 113.41, 116.16, 
119.11, 120.98, 124.59, 129.83, 133.42, 133.78, 136.49, 146.59, 161.18, 162.62, 
171.18, 187.65. Anal. Calcd for C16H120 4: C, 71.64; H, 4.51 Found: C, 71.63; H, 
4.60. 
Synthesis of 1-Hydroxy-3-methylanthraguinone-2-carboxylic Acid ( 45). 
Following the method outlined in 82, 6.49 g (111.1 mmol) of dry NaCl and 
40.10 g (300. 7 mmol) of AICl3 were placed in the reaction system. One solid 
addition funnel was charged with 1.94 g (13.1 mmol) of phthalic anhydride, and 
another solid addition funnel was filled with 2.04 g (12.3 mmol) of 44. The 
system was heated to 175 °C, and the phthalic anhydride was slowly added. 
After 1 O min, acid 44 was added and the reaction was allowed to proceed for 15 
min. The mixture was cooled until it began to thicken at 115 °C. At this point, 50 
g of ice and 25 ml of cone HCI were added. The solid was filtered and 
extracted. The resulting crude organic material was placed in hot CH2Cl2. The 
insoluble material was collected and crystallized from ethyl acetate-petroleum 
ether yielding 0.40 g (11.4%) of 45 as bright-yellow crystals, mp 277-278 °c (lit.71 
276 °C). 1H NMR (300 MHz, DMSO-d6) 0 2.29 (s, 3H), 6.75 (d, 1H), 6.99 (d, 1H), 
7.47(dd, 1H), 7.65-7.78(m,2H),8.02(dd, 1H), 12.18(brs, 1H), 13.34(brs, 
1H). 13C NMR (75 MHz, DMSO-d6) ~ 19.81, 114.34, 120.41, 126.65, 127.01, 
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132.66, 132.87, 132.99, 133.08, 134.80, 135.24, 144.10, 158.03, 167.15, 181.68, 
187.78. Anal. Calcd for C16H10O5: C, 68.09; H, 3.57. Found: C, 67.28; H, 3.55. 
Synthesis of 1-Hydroxy-3-methylanthraquinone-2-carbaldehyde 
A solution of 0.18 g (0.6 mmol) of 45 in 100 ml of anhydrous THF was 
placed in a 250-ml round-bottom flask and cooled to -78 °C. To this solution 
was injected 1.5 ml (1.5 mmol) of a 1.0 M solution of LAH in ethyl ether. After 
the reaction was allowed to stir for 1 h, the flask was warmed to RT and allowed 
to stir for an additional 6 h. The reaction was quenched with sodium sulfate 
decahydrate and diluted with ethyl ether. After filtration, the filtrate was washed 
with water and a saturated solution of NaCl. The organic layer was dried, and 
the solvent was evaporated. The crude organic residue was dissolved in 40 ml 
of anhydrous CH2Cl2 and placed in a 100-ml round-bottom flask. After 1.21 g 
(5.6 mmol) of PCC was added to the solution, the mixture was refluxed for 10 h. 
The reaction was quenched with a saturated solution of NaHCO 3 and diluted with 
additional CH2Cl2. The organic layer was washed with water and a saturated 
solution of NaCl, then dried and concentrated. The crude organic residue was 
subjected to silica gel column chromatography (CH2Cl2), yielding 14 mg (8.3%) of 
1-hydroxy-3-methylanthraquinone-2-carbaldehyde. 1H NMR (300 MHz, CDCl3) ~ 
2.51 (s, 3H), 7.49-7.96 (m, SH), 9.77 (s, 1H), 10.55 (s, 1H). ESI-MS (m/z): [M + 
Ht calcd for C16H10O4, 267.1; found 267.0; [M + Nat calcd for C16H10O4 , 289.0; 
found 288. 7. 
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2. Synthesis of Aldehyde Side Chain Synthon 
Synthesis of 2,5-Dihydro-thiophene-3-carbaldehyde (48) with Dehydration by 
MsCI and DIPEA. 
In a 1-l round-bottom flask, 14.04 g (92.2 mmol) of 1,4-dithiane-2,5-diol 
was dissolved in 450 ml of anhydrous CH2Cl2. A stirbar was added and the flask 
was cooled to 0 °C. With stirring, 20 ml (299.3 mmol) of 99% acrolein was 
added. The flask was fitted with a pressure-equalizing funnel filled with 34.0 ml 
(243.9 mmol) of Et3N dissolved in 15 ml of anhydrous CH2Cl2, and a positive-
pressure nitrogen line. The Et3N was added over 20 min with continuous stirring, 
and the mixture was allowed to stand at RT for 12 h. The additional funnel was 
replaced with a condenser, and the reaction was refluxed for 2 h. The reaction 
mixture was extracted with 1.0 M HCI, water and a saturated NaCl solution. The 
crude product 47 was dissolved in 350 ml of anhydrous CH2Cl2 and placed in a 
two-neck round-bottom flask. The flask was fitted with a magnetic stirbar, a 
condenser and a rubber septum. The flask was cooled to O °C and fitted with a 
positive-pressure nitrogen line. Next, 55.0 ml (315.7 mmol) of DIPEA was 
injected via syringe into the solution, and the mixture was allowed to sit for 1 O 
min, then 12 ml (155.0 mmol) of MsCI was slowly added via syringe. The 
reaction was allowed to warm to RT and stir for 4.5 h. The mixture was cooled 
and extracted with water, 1.0 M HCI and a saturated NaCl solution. The organic 
layer was dried and evaporated, producing a crude brown oil that was purified by 
silica gel column chromatography (CHCl3), yielding 3.22 (30.6%) of 48 as a 
yellow oil. 1H NMR (300 MHz, CDCl3) ~ 3.78-3.82 (m, 2H) 3.92-3.96 (m, 2H), 
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6.89 (t, 1 H), 9.75 (s, 1 H). 13C NMR (75 MHz, CDCl3) ~ 34.4, 39.0, 145.6, 148.5, 
187.3. 
Synthesis of 2,5-Dihydro-thiophene-3-carbaldehyde (48) with Dehydration by 
Molecular Sieves. 
In a 1-l round-bottom flask, 11.13 g (73.1 mmol) of 1,4-dithiane-2,5-diol 
was dissolved in 400 ml of anhydrous CH2Cl2. A stirbar was added and the flask 
was cooled to 0 °C. With stirring, 17.5 ml (235.7 mmol) of 90% acrolein was 
added. The flask was fitted with a pressure-equalizing funnel, filled with 30.0 ml 
(215.2 mmol) of Et3N dissolved in 15 ml of anhydrous CH2Cl2, and fitted with a 
positive-pressure nitrogen line. The Et3N was added over 20 min with continuous 
stirring and allowed to stand at RT for 12 h. The additional funnel was replaced 
with a condenser, and the mixture was refluxed for 2 h. At this point, a catalytic 
amount of TFA was added, along with 4 A sieves, and the mixture was refluxed 
for an additional 4 h. The reaction mixture was cooled and filtered to remove the 
sieves. The filtrate was extracted with 1.0 M HCI, water and a saturated NaCl 
solution. The organic layers were combined, dried and evaporated, yielding a 
viscous brown oil that was subjected to silica gel column chromatography 
(CHCl3), yielding 5.12 g (61.3%) of 48 as a yellow oil. 1H NMR (300 MHz, 
CDCl3) ~ 3.79-3.82 (m, 2H) 3.93-3.97 (m, 2H), 6.88 (t, 1 H), 9.76 (s, 1 H). 13C 
NMR (75 MHz, CDCl3) ~ 34.1, 38.9, 145.6, 148.4, 187.2. 
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Preparation of 1,2:5,6-Di-O-isopropylidene-o-mannitol (51 ). 
To a stirred solution of 33.50 g (0.249 mol) of anhydrous zinc(II) chloride 
in 250 ml of dry acetone was added 21.54 g (0.118 mol) of D-mannitol, dried in a 
vacuum oven at 50 °C for 20 h. The reaction mixture was allowed to stir for 3 h 
at RT. Unreacted D-mannitol (6. 78 g) was removed by vacuum filtration. The 
filtrate was added to a biphasic solution of 43.2 g of K2CO3 dissolved in 44 ml of 
water and 200 ml of ethyl ether and stirred vigorously for 45 min at RT. The 
mixture was filtered. The precipitate was washed twice with additional ethyl ether 
and combined with the filtrate and extracted with 100 ml of a saturated NaCl 
solution. The organic layer was collected, dried and concentrated, leaving a 
organic slurry, which was filtered. TLC (2: 1 ethyl acetate-petroleum ether) 
indicated a slight amount of tri-acetonide product. The product was purified by 
refluxing the collected product in a mixed solution of 1 mUg of CHCl3 and 1 0mUg 
of petroleum ether for 30 min followed by filtration through fluted filter paper.49 
An additional 100 ml of petroleum ether was added to the filtrate and cooled at O 
°C for 2 h. The solid was collected and dried, yielding 11.77 g (55.4%, based 
upon amount of o-mannitol originally dissolved) of 51; mp 118-119 °c (lit. 72 
118-119 °C). 
Preparation of lsopropylidene Glyceraldehyde (50). 
To a stirred suspension of 5.02 g (19.1 mmol) of 51 in 100 ml of a 5% 
NaHCO3 solution at 0 °C was added dropwise 4.95 (23.1 mmol) of NalO4 
dissolved in 60 ml of water. After the addition was complete, the reaction 
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mixture was warmed to RT and stirred for 1 h. TLC analysis (2: 1 ethyl 
acetate-petroleum ether) indicated that the reaction was complete. Note: the 
product spot appeared lower than that of the starting carbohydrate starting 
material since the acidic TLC plate hydrates the aldehyde. The aqueous layer 
was extracted with CH2Cl2 three times. The organic layers were combined, dried 
and evaporated. Once the solvent was removed, the reaction yielded 2.14 g 
(43.0%) of 50. The product was re-dissolved in 25.0 ml of dry THF (0.659 M 
solution) and stored over CaSO4 to avoid hydrate formation. IR (KBr) 1736.97. 
Preparation of 4-(2-Methoxy-ethoxymethoxymethyl}-2,2-dimethyl-[1,3]dioxolane 
(52). 
In a 250 round-bottom flask, fitted with a magnetic stirbar, rubber septum 
and positive-pressure nitrogen line was placed 1.61 g (40.3 mmol) of cleaned 
NaH and 150 ml of anhydrous THF. The flask was cooled to O °C, and a 
solution of 3.58 g (27.1 mmol) of solketal dissolved in 5 ml of anhydrous THF 
was injected via syringe over 15 min. After an additional 15 min at O °C, a 
solution of 5.01 g (40.2 mmol) of MEMCI dissolved in 10 ml of anhydrous THF 
was injected. The mixture was allowed to warm to RT over 2.5 h, then it was 
slowly quenched with water and diluted with ethyl ether. The organic layer was 
washed with a saturated solution of NaCl, dried and evaporated, yielding 4.25 g 
(71.3%) of 52 as an oil. 1H NMR (250 MHz, CDCl3) l> 1.37 (s, 3H), 1.43 (s, 3H), 
3.39 (s, 3H), 3.54-3.75 (m, 7H), 4.07 (m, 1 H), 4.31 (m, 1 H), 4.75 (s, 2H). 13C 
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NMR (63 MHz, CDCl3) ~ 25.36, 26.57, 58.80, 66.66, 66.92, 68.75, 71.88, 74.67, 
95.56, 109.33. 
Preparation of 3-(2-Methoxyethoxymethoxy)-propane-1,2-diol (53). 
In a 50-ml round-bottom flask, fitted with a magnetic stirbar, rubber 
septum and positive-pressure nitrogen line, was placed 1.50 g (6.8 mmol) of 52 
in 30 ml of anhydrous methanol. To this solution was added via syringe 
approximately 3 ml of a 0.1 M solution of HCI. After the reaction mixture was 
allowed to stir for 12 h, CHCl3 was added and separated. The organic layer was 
washed with water, and a saturated solution of NaCl, dried, and evaporated, 
yielding 0.34 g (28.0%) of 53. 1H NMR (250 MHz, CDCl3) ~ 3.40 (s, 3H), 
3.55--3.74 (m, 9H), 4.77 (m, 2H). 13C NMR (63 MHz, CDCl3) ~ 59.00, 63.69, 
67.21, 70.34, 70.72, 71.76, 96.02. 
Synthesis of 1-(tert-Butyldimethylsilyloxy)-3-(2-methoxyethoxymethoxy)-
propan-2-ol (54). 
A solution of 0.53 g (3.0 mmol) of diol 53 in 50 ml of anhydrous CH2Cl2 
was placed in a 250-ml round-bottom flask. To the flask was added a solution of 
0.48 g (3.2 mmol ) of TBSCI and 0.02 g (0.1 mmol) of DMAP in 10 ml of 
anhydrous CH2Cl2. 73 The flask was fitted with a rubber septum and a positive-
pressure nitrogen line and cooled to -15 °c. Next, 0.5 ml (3.6 mmol) of Et3N 
was slowly added via syringe over 15 min. Once the mixture had stirred at RT 
for 14 h, it was quenched with a saturated solution of NH4CI. The organic layer 
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was washed with water and a saturated solution of NaCl, dried and evaporated. 
The crude organic residue was subjected to silica gel column chromatography 
(3:1 petroleum ether-ethyl acetate), yielding 0.53 g (60.0%) of 54 as an oil. 1H 
NMR (250 MHz, CDCl3) l) 0.07 (s, 6H), 0.90 (s, 9H), 3.40 (s, 3H), 3.55--3.74 (m, 
9H), 4. 75 (m, 2H). 13C NMR (75 MHz, CDCl3) l) -5.44, 25.84, 59.00, 63.92, 
66.76, 66.95, 69.54, 70.76, 71.71, 95.97. 
Synthesis of 1-(tert-Butyldimethylsilyloxy)-3-(2-methoxyethoxymethoxy)-propan-
2-one (55). 
In a 100-ml round-bottom flask fitted with a rubber septum and a positive-
pressure nitrogen line was placed 0.25 ml (2.9 mmol) of oxalyl chloride and 30 
ml of anhydrous CH2Cl2_ After the flask was cooled to -78 °C, a solution of 0.4 
ml (5.6 mmol) of DMSO dissolved in 5 ml of anhydrous CH2Cl2 was injected via 
syringe over 5 min.74·75 Stirring was continued at -78 °c for 15 min, at which 0.74 
g (2.5 mmol) of 54 dissolved in 1 O ml of anhydrous CH2Cl2 was injected over 5 
min. The mixture was stirred for an additional 45 min at -78 °C. Next, 1.9 ml of 
Et3N was injected, and the mixture stirred for 1 hat -78 °C then warmed to RT 
over 45 min. The reaction was quenched with a saturated solution of NH4CI, and 
the organic layer was separated. The organic layer was washed with water and 
a saturated solution of NaCl, dried, concentrated and subjected to silica gel 
column chromatography (5:1 petroleum ether-ethyl acetate), yielding 0.32 g 
(44.7%) of 55 as an oil. 1H NMR (300 MHz, CDCl3) l) 0.02 (s, 6H), 0.85 (s, 9H), 
3.31 (s, 3H), 3.47-3.67 (m, 8H), 4.71 (m, 2H). 13C NMR (75 MHz, CDCl3) ~ -
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In a 50-ml round-bottom flask, 0.37 g (1.3 mmol) of 55 was dissolved in 
15 ml of dry THF. The flask, which was fitted with a magnetic stirbar, a rubber 
septum and a positive-pressure nitrogen line, was cooled to -78 °C. Next, 2.0 ml 
(2.0 mmol) of a 71.0 M solution of vinylmagnesium bromide in hexane was slowly 
injected via syringe over 3 min. The mixture was allowed to stand at -78 °C for 1 
h, then 4 h at RT. The mixture was quenched with 1 M HCI and extracted with 
ethyl ether. The organic layer was washed with water and a saturated solution of 
NaCl, dried, and the solvent was evaporated. The reaction yielded 0.39 g 
(97.5%) of 56 as a yellow oil. 1H NMR (300 MHz, CDCl3) l> 0.05 (s, 6H), 0.89 (s, 
9H), 3.39 (s, 3H), 3.54-3.72 (m, 6H), 4.74 (s, 2H), 5.24 (d, J = 10.3 Hz, 1 H), 5.45 
(d, J= 17.2 Hz, 1H), 5.92 (dd, J= 17.2, 10.3 Hz, 1H). 13C NMR (75 MHz, CDCl3) 




To a 100-ml round-bottom flask was added 1.07 g (3.3 mmol) of 56, 0.80 
g (5.3 mmol) of TBSCI and 50 ml of anhydrous CH2Cl2. Once the flask was 
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fitted with a rubber septum, a positive-pressure nitrogen line and cooled to 0 °C, 
0.6 ml (5.2 mmol) of 2,6-lutidine was injected via syringe. After the reaction was 
allowed to warm to RT over 14 h, the mixture was quenched with a saturated 
solution of NH4CI. The organic layer was washed with water and a saturated 
solution of NaCl, then dried, evaporated and subjected to silica gel column 
chromatography (3:1 petroleum ether-ethyl acetate), yielding 0.80 g (55.0%) of 
57 as a yellow oil. 1H NMR (300 MHz, CDCl3) c5 0.02 (s, 6H}, 0.47 (s, 6H), 0.84 
(s, 9H}, 0.86 (s, 9H}, 3.34 (s, 3H}, 3.46-3.67 (m, 6H}, 4.69 (s, 2H), 5.17 (d, J = 
10.5 Hz, 1 H), 5.38 (d, J = 17.4 Hz, 1 H), 5.86 (dd, J = 17.4, 10.6 Hz, 1 H). 13C 
NMR (75 MHz, CDCl3} l)-5.62, -3.71, 17.86, 18.12, 25.54, 25.70, 58.87, 66.38, 
66.80, 71.35, 71.56, 7 4.48, 95.86, 115.11, 138.50. 
Preparation of Dimethylboron Bromide. 
A 50-ml three-neck round-bottom flask with a magnetic stirbar was fitted 
with a rubber septum, a short-path distillation apparatus and a ground-glass 
stopper. The collection flask was a pre-weighed 50-ml three-neck round-bottom 
flask fitted with two rubber septa. The reaction flask was cooled to -45 °C and 
flushed thoroughly with nitrogen. [Note: the boron tribromide will partially freeze 
in the reaction flask at -48 °C, so the reaction was performed at -45 °C.] The 
reaction flask was charged with 4.8 ml (50.8 mmol) of boron tribromide. After 5 
min, 7.0 ml (50.5 mmol) of tetramethyl stannate was injected dropwise via 
syringe. 55 After the reaction mixture was allowed to stand at -45 °C for 0.5 h, the 
rubber septum in reaction flask was replaced with a ground-glass stopper and 
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allowed to stand for an additional 0.5 h at RT. The reaction mixture was distilled 
(oil bath temperature, 65 °C) and the product was collected at 31-32 °C. By 
weighing the collection flask and eliminating the weight of the added CH2Cl2, it 
was determined that 4.95 g (81.1 %) of dimethylboron bromide was synthesized, 
which exists as a 1. 71 M solution in CH2Cl2. 
Preparation of 2,2-Dimethyl-4-[( 4-methoxyphenyl)methoxymethyl]-1,3-dioxolane 
(59). 
A slurry mixture of 8.59 g (76.5 mmol) of potassium tert-butoxide and 100 
ml of dry THF was placed in a 500 ml round-bottom flask, fitted with a rubber 
septum and a positive-pressure nitrogen line, and cooled to O °C. A solution of 
9.30 g (70.4 mmol) of 2,2-dimethyl-1,3-dioxolane-4-methanol in 40 ml of dry 
THF was slowly injected via syringe. After 0.5 h the solution turned to a 
yellowish-brown color, and at this point 10.4 ml (76. 7 mmol) of 4-methoxybenzyl 
chloride was injected into the reaction mixture. After 18 h, the solvent was 
evaporated, leaving a residue that was subsequently treated with 80 ml of water 
and extracted with three portions of 75 ml of ethyl ether. The collected organic 
layers were combined, extracted with 75 ml of a saturated solution of NaCl, 
dried, and the ether was evaporated yielding 17.51 g (98.6%) of 59 as a yellow 
oil. 
Alternatively, a slurry of 1.53 g (60.0 mmol) of 95% sodium hydride and 
150 ml of dry DMF was placed in a 250-ml round-bottom flask, which was fitted 
with a magnetic stirbar, rubber septum and positive-pressure nitrogen line, was 
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cooled to 0 °C. A solution of 7.80 g (59.0 mmol) of 2,2-dimethyl-1,3-dioxolane-4-
methanol and 10 ml of dry DMF was slowly injected via syringe. After 10 min, 
4.36 g (11.8 mmol) of tetrabutylammonium iodide was added, followed by 8.0 ml 
(59.0 mmol) of 4-methoxybenzyl chloride. The reaction mixture was stirred at 0 
°C for an additional 15 min, then warmed to RT for 12 h. The solvent was 
evaporated and the organic residue was dissolved into CHCl3 and extracted with 
water and a saturated solution of NaCl. The organic layer was dried and 
evaporated. 
For both methods, the crude organic residue was subjected to silica gel 
column chromatography (4:1 petroleum ether-ethyl acetate). The reaction using 
NaH yielded 2.34 g (18.9%) of the pure product. 1H NMR (300 MHz, CDCl3) ~ 
1.35 (s, 3H), 1.41 (s, 3H), 3.43--4.27 (m, SH), 3.74 (s, 3H), 4.50 (s, 2H), 6.86 (d, 
2H), 7.28 (d, 2H). 13C NMR (75 MHz, CDCl3) ~ 24.64, 26.37, 55.67, 66.58, 
71.81, 73.33, 7 4.49, 109.68, 113.94, 129. 71, 129.98, 159.05. 
Svnthesis of 3-[(4-Methoxvphenvl}methoxv)-1,2-propanediol {60). 
A solution of 17.51 g (69.4 mmol) of 59 dissolved in 150 ml of methanol 
was placed into a 250-ml round-bottom flask and fitted with a magnetic stirbar. 
As the solution slowly stirred, 20 ml of 1.0 M HCI was added dropwise. A rubber 
septum and positive-pressure nitrogen line was added to flask, and the reaction 
was allowed to stand for 1 h. The solvent was evaporated, and the resulting 
residue was treated with 150 ml of water and extracted with three portions of 
150 ml of ethyl acetate. The organic layers were combined, extracted with 75 
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ml of a saturated sodium chloride solution, dried, and evaporated yielding 60 as 
an oil. The crude product was subjected to silica gel column chromatography 
(2% methanol in CHCl3), which yielded 7.01 g (47.6%) of the product. 1H NMR 
(300 MHz, CDCl3) 6 3.37 (s, 2H), 3.81 (s, 3H), 4.40-4.57 (m, SH), 6.90 (d, 2H), 
7.28 (d, 2H). 13C NMR (75 MHz, CDCl3) 6 46.57, 55.51, 58.08, 73.34, 74.60, 
114.00, 129.62, 130.32, 159.44. 
Synthesis of 1-tert-Butyldimethylsilyloxy-3-[4-(methoxyphenyl)methoxy]-2-
propanol (61 ). 
A solution of 5.07 g (23.9 mmol) of diol 60 and 100 ml of anhydrous 
CH2Cl2 were placed into a 250-ml round-bottom flask, fitted with a magnetic 
stirbar, rubber septum and a positive-pressure nitrogen line, and cooled to -78 
°C. After 5 min, a solution of 3.77 g (25.0 mmol) of TBSCI and 0.12 g (0.95 
mmol) of DMAP in 20 ml of anhydrous CH2Cl2 was slowly injected via syringe 
into the flask. After the solution was allowed to stand for 10 min, 3.8 ml (27.3 
mmol) of anhydrous Et3N was injected into the reaction flask, then allowed to 
warm to RT over 16 h. The solution was quenched with saturated NH4CI and 
extracted with a saturated solution of NaCl and water. The aqueous layers were 
combined and extracted with two 50-ml portions of CH2Cl2• The organic layers 
were combined, dried, and evaporated yielding 5.98 g (76.7%) of 61. 1H NMR 
(300 MHz, CDCl3) 6 0.10 (s, 6H), 0.92 (s, 9H), 3.36 (s, 2H), 3.80 (s, 3H), 
4.40-4.57 (m, SH), 6.88 (d, 2H), 7.28 (d, 2H). 13C NMR (75 MHz, CDCl3) 6 -5.78, 
26.02, 55.72, 64.56, 64.91, 70.74, 71.98, 73.67, 113.17, 127.55, 128. 61, 159.01. 
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3. Reactions Involved in Aldol Consendation Chemistry 
Synthesis of 3-Hydroxy-1-(2-hydroxyphenyl}-3-( 4-methoxyphenyl}-propan-1-one 
.a.11. 
In a 100-ml round-bottom flask fitted with a magnetic stirbar, a positive-
pressure nitrogen line and rubber septum was placed 40 ml of anhydrous THF. 
The flask was cooled to -78 °C, then 17 ml (34 mmol) of a 2.0 M solution of LOA 
in THF-heptane-ethyl benzene was added via syringe. A solution of 1.01 g 
(7.42 mmol) of 2'-hydroxyacetophenone dissolved in 15 ml of anhydrous THF 
was slowly added via syringe. After the reaction mixture was allowed to stand at 
-78 °C for 45 min, a solution of 1.11 g (8.15 mmol) of p-anisaldehyde dissolved in 
1 O ml of anhydrous THF was added and the mixture was allowed to stand for 1 O 
h, slowly warming to RT. The organic reaction mixture was quenched with a 
saturated NH4CI solution and extracted with a saturated NaCl solution and water. 
The organic layer was dried, evaporated and subjected to silica gel column 
chromatography (3:1 petroleum ether-ethyl acetate), yielding 0.31 g (15.3%) of 
71. 1H NMR (300 MHz, CDCl3) ~ 3.15 (br s, 1 H), 3.31-3.49 (m, 2H), 3.82 (s, 3H), 
5.31 (dd, 1H), 6.86-7.72 (m, 8H), 12.10 (s, 1H). 13C NMR (300 MHz, CDCl3) ~ 
47.36, 55.58, 69.79, 114.25, 118.90, 119.36, 119.63, 127.27, 130.29, 135.08, 
137 .12, 159.50, 162.80, 205. 77. 
Synthesis of 1-(2-Hydroxyphenyl}-3-( 4-methoxyphenyl}-propenone (72). 
To a 100-ml round-bottom flask, fitted with a positive-pressure nitrogen 
line and a stirbar, was added 0.309 g (1.1 mmol) of 71 and 40 ml of anhydrous 
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THF. Approximately 1 g of pre-charged Amberlite CG-50 [H+] ion-exchange resin 
in methanol was added, and the reaction was refluxed for 18 h. The mixture was 
filtered through fluted filter paper to remove the resin beads. The organic filtrate 
was concentrated and subjected to silica gel column chromatography (3: 1 
petroleum ether-ethyl acetate), yielding 0.178 g (61.6%) of 72. 1H NMR (300 
MHz, CDCl3) c5 3.83 (s, 3H), 6.95--8.22 (m, 10H), 12.89 (s, 1H). 
Synthesis of 2-(4-Methoxyphenyl)chromen-4-one (73). 
A solution of 0.178 g (0. 70 mmol) of 72 dissolved in 50 ml of terl-amyl 
alcohol was placed in a 100-ml round-bottom flask and fitted with a magnetic 
stirbar. Selenium dioxide (0.112 g, 1.01 mmol) was added, and a rubber septum 
with a positive-pressure nitrogen line was fitted onto the flask.3 The reaction 
mixture was heated to 65 °C and allowed to stand for 18 h. The reaction mixture 
was filtered through a Celite pad and concentrated. The residue was subjected 
to silica gel column chromatography (3:1 petroleum ether-ethyl acetate), yielding 
16 mg (9.1 %) of 73. Also isolated from the column was 0.11 g (61.8%) of the 
starting material. This material was redissolved in terl-amyl alcohol and placed in 
a 100-ml round-bottom flask with 95 mg (0.86 mmol) of selenium dioxide, and 
the reaction repeated. This reaction yielded 25 mg (22.9%) of 73, giving an 
overall yield of 22.7%. 1H NMR (300 MHz, CDCl3) c5 3.90 (s, 3H), 6.76 (s, 1 H), 
7.04 (d, 2H), 7.43 (dd, 1 H), 7.55 (d, 1 H), 7.69 (dd, 1 H), 7.90 (d, 2H), 8.23 (d, 1 H). 
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13C NMR (75 MHz, CDCl3) ~ 28.69, 54.50, 105.18, 113.44, 116.95, 122.91, 
123.01, 124.07, 124.65, 127.00, 132.56, 161.36, 162.39, 177.41. 
Synthesis of 3-(2,2-Dimethyl-[1,3ldioxolan-4-yl)-3-hydroxy-1-(2-
hydroxyphenyl)propan-1-one (7 4 ). 
In a 250-ml round-bottom flask fitted with a magnetic stirbar, a positive-
pressure nitrogen line and rubber septum was placed 100 ml of anhydrous THF. 
Once the flask was cooled to -78 °C, 20 ml (40 mmol) of a 2.0 M solution of lDA 
in THF-heptane was added via syringe. A solution of 1.50 g (11.02 mmol) of 2'-
hydroxyacetophenone dissolved in 15 ml of anhydrous THF was slowly added 
via syringe. After the reaction mixture was allowed to stand at -78 °C for 2 h, a 
solution of 1.34 g (10.26 mmol) of O-isopropylidene glyceraldehyde dissolved in 
10 ml of anhydrous THF was added, and the mixture was allowed to stand for 
10 h, slowly warming to RT. The organic reaction mixture was quenched with a 
saturated NH4CI solution and extracted. The aqueous layer was washed with 
ethyl ether and combined with the original organic layer and concentrated. The 
crude organic residue was subjected to silica gel column chromatography (3:1 
petroleum ether-ethyl acetate), yielding 0.76 g (27.8%) of 74 as a yellow-orange 
solid. 1H NMR (300 MHz, CDCl3) ~ 1.37 (s, 3H), 1.42 (s, 3H), 1.49 (br s, 1H) 
3.15 (m, 2H), 4.03-4.17 (m, 3H), 6.93 (dd, 1H), 6.99 (d, 1H), 7.50 (dd, 1H), 7.78 
(dd, 1H), 12.02 (s, 1H). 13C NMR (75 MHz, CDCl3) ~ 25.13, 26.36, 26.74, 41.55, 




To a 100-ml round-bottom flask fitted with a magnetic stirbar, rubber 
septum and a positive-pressure nitrogen line was added 20 ml of anhydrous 
THF and 8.0 ml (16.0 mmol) of a 2.0 M LOA solution in THF. After the flask was 
cooled to -78 °C, a solution of 2.73 g (10.9 mmol) of 68 dissolved in 10 ml of 
anhydrous THF was slowly injected via syringe, and the mixture was stirred for 
40 min. Next, 1.33 g (10.2 mmol) of 50 dissolved in 25 ml of anhydrous THF 
was slowly injected and stirring was continued for 14 h, as the flask was allowed 
to warm to RT. The mixture was quenched with a saturated NH4CI solution and 
extracted ethyl ether. The aqueous layer was washed with additional ethyl ether. 
The ether was combined with the original organic layer, which was dried and 
evaporated, yielding 3.36 g (8.8 mmol; 86.6%) of the crude ~-hydroxy 
intermediate 75 determined by 1H NMR spectroscopy and TLC. This crude 
residue was dissolved in 50 ml of anhydrous CH2Cl2 and placed in a 100-ml 
round-bottom flask fitted with a magnetic stirbar and a positive-pressure nitrogen 
line. After cooling the flask to O °C, 1.5 ml (10.8 mmol) of Et3N was injected, 
followed by 0.8 ml (10.3 mmol) of MsCI. Once the additions were complete, the 
flask was warmed to RT and allowed to stir for 2 h, at which time a small aliquot 
of Et3N was added and stirring was continued for 1 h. The mixture was 
quenched with a saturated NH4CI solution and extracted. The aqueous layer was 
washed with additional CH2Cl2. The organic layers were combined, dried and 
evaporated. The crude organic residue was subjected to silica gel column 
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chromatography (4:3 petroleum ether-ethyl acetate), which yielded 0.4 g (12.9%) 
of 76. 1H NMR (300 MHz, CDCl3) ~ 0.20 (s, 6H), 0.96 (s, 9H), 1.41 (s, 3H), 1.44 
(s, 3H), 3.67 (dd, 2H), 4.70 (m, 1 H), 6.80 (d, 1 H), 6.87 (dd, 1 H) 6.93 (d, 1 H), 7.01 
(dd, 1 H), 7.35 (dd, 1 H), 7.47 (dd, 1 H). 13C NMR (75 MHz, CDCl3) ~ -4.21, 18.22, 
25.71, 26.52, 68.78, 75.42, 110.04, 120.30, 121.40, 130.13, 130.81, 131.58, 
132.55, 142.75, 154.06, 193.35. 
4. Procedures for Synthesis of Aromatic Derivatives 
Preparation of 2-Methoxy-6-methylbenzaldehyde (38). 
In a 1-L round-bottom flask was combined 5.04 g (37.0 mmol) of 2,3-
dimethylanisole, 9.50 g (38.0 mmol) of copper(II) sulfate pentahydrate and 30.85 
g ( 114.1 mmol) of K2S2O8 along with 500 ml of 1: 1 CH3CN-water and a 
magnetic stirbar. 35•36 The flask was fitted with a condenser and heated to reflux 
while the contents were rapidly stirred. The reaction mixture was monitored by 
TLC (4:1 petroleum ether-ethyl acetate), and after 2 h the reaction was 
complete. After the reaction vessel was cooled to RT, 500 ml of ethyl acetate 
was added. The copper salts can be either dissolved in additional water or 
filtered off. The organic layer was collected and dried, and the solvent was 
evaporated. The residue was then subjected to silica gel column 
chromatography (4:1 petroleum ether-ethyl acetate), yielding 3.77 g (67.8%) of 
38; mp 40-42 °C (lit.36 41-42 °C). 1H NMR (300 MHz, CDCl3) ~ 2.56 (s, 3H), 
3.87 (s, 3H), 6.77-6.83 (m, 2H), 7.36 (dd, 1 H), 10.62 (s, 1 H). 13C NMR (75 MHz, 
CDCl3) ~ 21.37, 55.61, 108.92, 123.13, 123.95, 134.36, 141.84, 163.04, 192.16. 
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Preparation of 1-(2-Methoxy-6-methylphenyl}ethanol (39). 
In a dry 250-ml round-bottom flask was placed 2.55 g (17.0 mmol) of 38, 
dissolved in 150 ml of dry THF, and a magnetic stirbar. A rubber septum 
allowed for the flask to be evacuated and re-pressurized with dry nitrogen. After 
cooling the flask to -78 °C, 14.0 ml (22.4 mmol) of a 1.6 M solution of Meli in 
ethyl ether was slowly injected into the reaction flask via syringe. The mixture 
was allowed to stand for 10 h, and it slowly warmed to RT. The reaction mixture 
was quenched slowly with a saturated NH4CI solution, then extracted with a 
saturated NaCl solution and water. The resulting aqueous layers were extracted 
with additional ethyl ether. The organic layers were combined, dried and 
evaporated, yielding 2.56 g (90.1 %) of 39 as a yellow oil,34 which was used 
without further purification. 1H NMR (300 MHz, CDCl3) ~ 1.52 (d, 3H), 2.31 (s, 
3H), 3.87 (s, 3H), 5.06 (m, 1 H), 6.76--6.81 (m, 2H), 7.11 (t, 1 H). 13C NMR (75 
MHz, CDCl3) ~ 19.87, 23.38, 55.58, 67.57, 109.43, 117.29, 123.82, 127.72, 
135. 79, 146.81. 
Preparation of 2-Methoxy-6-methylacetophenone (40). 
A solution of 2.53 g (15.2 mmol) of 39 dissolved in 150 ml of anhydrous 
toluene was placed, along with a magnetic stirbar, in a 250-ml round-bottom 
flask. After adding 2.32 g (26. 7 mmol) of MnO2, the flask was fitted with a 
condenser and refluxed for 14 h.11>7s The reaction was monitored by TLC (5:1 
petroleum ether-ethyl acetate). The reaction flask was cooled, and the solution 
was filtered through Celite. The filtrate was filtered a second time through a 
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simple fluted filter paper funnel to eliminate the small amount of MnO2 that 
escaped from the original Celite filter. The second filtrate was evaporated, and 
the organic residue subjected to silica gel column chromatography (5:1 
petroleum ether-ethyl acetate), yielding 2.35 g (94.0%) of 40, as a yellow oil.34 
1H NMR (300 MHz, CDCl3) ?> 2.23 (s, 3H), 2.48 (s, 3H), 3.80 (s, 3H), 6.73-6.80 
(m, 2H), 7.20 (t, 1 H). 13C NMR (75 MHz, CDCl3) ?> 18.9, 32.1, 55.4, 108.2, 122.8, 
129.7, 131.2, 135.2, 156.1, 205.5. 
Preparation of 2-Methoxy-6-methylacetophenone (40). 
A solution of 2.56 g (15.4 mmol) of 39 dissolved in anhydrous CH2Cl2 was 
placed, along with a magnetic stirbar, in a 250-ml round-bottom flask. The flask 
was cooled to O °C and 9.15 g (24.3 mmol) of PDC was added. The flask was 
fitted with a drying tube and reacted for 30 min at O °C, then 14 hat RT. The 
reaction was monitored by TLC (5:1 petroleum ether-ethyl acetate). The solution 
was filtered through Ce lite to remove the majority of the solid impurities and 
excess PDC. The filtrate was run through a short silica gel column, using 
CH2Cl2 as an elution solvent to remove the remaining PDC from the solution. 
The second filtrate was evaporated and subjected to silica gel column 
chromatography (5:1 petroleum ether-ethyl acetate), yielding 1.85 g (73.1%) of 
40 as a yellow oil. 1H NMR (300 MHz, CDCl3) ?> 2.23 (s, 3H), 2.48 (s, 3H), 3.80 
(s, 3H), 6.73--6.80 (m, 2H), 7.20 (t, 1H). 13C NMR (75 MHz, CDCl3)?) 18.9, 32.1, 
55.4, 108.2, 122.8, 129.7, 131.2, 135.2, 156.1, 205.5. 
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Preparation of 2-Hydroxy-6-methylacetophenone (69). 
In a three-neck 100-ml round-bottom flask, fitted with an pressure-
equalizing funnel, two septa and a positive-pressure nitrogen line, 15 ml of 
anhydrous CH2Cl2 was cooled to -78 °C. The funnel was filled with a solution of 
1.16 g (7. 06 mmol) of 40 dissolved in 20 ml of anhydrous CH2Cl2 and 0. 7 ml 
(7 .40 mmol) of boron tribromide was injected via syringe to the flask, and the 
solution of 40 was added dropwise over 30 min. 76 The mixture was allowed to 
warm to RT while it stirred for 14 h. The solution was quenched with 50 ml of 
water. The organic layer was separated, and the aqueous layer was washed 
with additional CH2Cl2. The organic layers were combined, extracted with 
saturated NaCl, dried and evaporated, leaving a brown oily residue. The oil was 
passed through a short column of silica gel (1 :1 petroleum ether-ethyl ether) to 
remove polar impurities. The filtrate was distilled using a short-path distillation 
apparatus, yielding 0.47 g (44.3%) of 69; bp 82 °C/0.5 torr (lit.76 138-142 °C/18 
torr). 1H NMR (300 MHz, CDCl3) ~ 2.59 (s, 3H), 2.66 (s, 3H), 6.72 (d, 1 H), 6.83 
(d, 1 H), 7.27 (t, 1 H), 12.30 (s, 1 H). 13C NMR (75 MHz, CDCl3) ~ 24.4, 33.3, 
116.4, 121.6, 123.0, 134.6, 139.4, 162.6, 206.1. In addition to the short-path 
distillation, it was possible to purify 69 via silica gel column chromatography (7:1 
petroleum ether-ethyl acetate). Both purification methods were utilized and were 
successful. 
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Synthesis of (2-tert-Butyldimethylsilyl)-6-methylacetophenone (70). 
In a 100-ml round-bottom flask, fitted with a magnetic stirbar, was 
combined 1.48 g (9. 9 mmol) of 69, 2.19 g ( 14.5 mmol) of TBSCI, 0.15 g ( 1.2 
mmol) of DMAP and 50 ml of anhydrous DMF. A rubber septum and positive-
pressure nitrogen line were added to the flask. After the mixture was allowed to 
stir for 20 min, 2.5 ml (17.9 mmol) of anhydrous Et3N was injected via syringe 
and stirring was continued for 14 h. The reaction mixture was quenched by 
pouring the mixture over 50 g of ice and 25 ml of a saturated NH4CI solution. 
This mixture was extracted with several aliquots of ethyl ether, which were 
combined, dried and concentrated yielding 2.26 g (86.7%) of 70 as an orange oil. 
Further purification was not needed. 1H NMR (300 MHz, CDCl3) ~ 0.20 (s, 6H), 
0.96 (s, 9H), 2.21 (s, 3H), 2.49 (s, 3H), 6.66 (d, 1 H), 6.78 (d, 1 H), 7.11 (dd, 1 H). 
13C NMR (75 MHz, CDCl3) ~ -4.31, 18.09, 19.02, 25.62, 32.28, 116.40, 123.20, 
129.43, 134.05, 135.31, 151.90, 206.03. 
Synthesis of 6-Methylsalicylaldehyde (80). 
To a stirred solution of 4.30 g (28.6 mmol) of 38 dissolved in 80 ml of 
anhydrous CH2Cl2, under nitrogen at RT, was added dropwise 3.8 ml (40.2 
mmol) of boron tribromide. After 1 h, the mixture was carefully poured over 50 g 
of ice. The aqueous layer was separated and washed with several aliquots of 
CH2Cl2, which were combined with the original organic layer, dried and 
concentrated into an oil. The crude residue was subjected to flash silica gel 
column chromatography (CH2Cl2) to yield 3.14 g (80.5%) of 80 as an oil. 1H NMR 
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(300 MHz, CDCl3) ~ 2.60 (s, 3H), 6.70 (d, 1 H), 6.80 (d, 1 H), 7.37 (dd, 1 H), 10.30 
(s, 1 H), 11.91 (s, 1 H). 13C NMR (75 MHz, CDCl3) ~ 18.04, 115.00, 118.42, 
137.36, 142.07, 163.06, 195.27. 
Synthesis of 2-(tert-Butyldimethylsilyloxy)-6-methylbenzaldehyde (81 ). 
To a stirred solution of 2.96 g (21.7 mmol) of 80, 5.20 g (34.5 mmol) of 
TBSCI, 0.45 g (3.7 mmol) of DMAP in 100 ml anhydrous DMF under nitrogen 
was added 6. 0 ml ( 43.1 mmol) of Et3N via syringe at RT. After 14 h, the reaction 
mixture was poured over 75 g of ice, then extracted with several aliquots of ethyl 
ether. The organic layers were combined, dried and concentrated, leaving a 
orange-yellow oil, which was subjected to silica gel column chromatography (2% 
ethyl acetate in petroleum ether) resulting in 3.30 g (60.6%) of 81 as a yellow oil. 
1H NMR (300 MHz, CDCl3) ~ 0.26 (s, 6H), 1.00 (s, 9H), 2.56 (s, 3H), 6.72 (d, 1 H), 
6.80 (d, 1H), 7.29 (dd, 1H), 10.63 (s, 1H). 13C NMR (75 MHz, CDCl3) ~ -4.28, 
18.34, 21.55, 25.68, 117.48, 124.58, 125.62, 134.29, 142.09, 160.15, 192.72. 
Anal. Calcd for C14H220 2Si: C, 67.15; H, 8.86. Found: C, 67.50; H, 8.72. 
Synthesis of 2' -tert-Butyldimethylsilyloxyacetophenone analog (68). 
In a 500-ml round-bottom flask, fitted with a magnetic stirbar, was 
combined 6.98 g (51.3 mmol) of 2'-hydroxyacetophenone, 7.79 g (51.7 mmol) of 
TBSCI, 0.29 g (2.4 mmol) of DMAP and 250 ml of anhydrous DMF. A rubber 
septum and positive-pressure nitrogen line were added to the flask. After the 
mixture was allowed to stir for 20 min, 8.0 ml (57.4 mmol) of anhydrous Et3N 
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was injected via syringe, and stirring was continued for 14 h. The reaction 
mixture was quenched by pouring it over 100 g of ice, and the mixture was 
extracted with several aliquots of ethyl ether. The organic layer was separated, 
dried and concentrated leaving an orange oil, which after being subjected to silica 
gel flash column chromatography (3:1 petroleum ether-ethyl acetate) yielded 
12.16 g (94.7%) of 68 as an oil. 1H NMR (300 MHz, CDCl3) 6 0.29 (s, 6H), 1.02 
(s, 9H), 2.62 (s, 3H), 6.88 (d, 1 H), 6.99 (dd, 1 H), 7.35 (dd, 1 H), 7.61 (d, 1 H). 13C 
NMR (75 MHz, CDCl3) 6 -4.10, 18.31, 25.74, 31.20, 120.08, 121.05, 129.84, 
131.22, 132.76, 154.52, 200.72. 
Synthesis of 2-(tert-Butyldimethylsilyloxy)benzaldehyde (79). 
To a stirred solution of 5.86 g (48.0 mmol) of salicylaldehyde, 10.61 g 
(70.4 mmol) of TBSCI, 0. 71 g (5.8 mmol) of DMAP in 150 ml anhydrous DMF 
under nitrogen was added 10.2 ml (73.2 mmol) of Et3N via syringe at RT. After 
14 h, the reaction mixture was poured over 75 g of ice, then extracted with 
several aliquots of ethyl ether. The organic layers were combined, dried and 
concentrated, leaving a orange-yellow oil, which was subjected to silica gel 
column chromatography (2% ethyl acetate in petroleum ether) resulting in 10.20 
g (89.9%) of 79 as a yellow oil. 1H NMR (300 MHz, CDCl3) 6 0.24 (s, 6H), 0.98 
(s, 9H), 6.85 (d, 1H), 6.99 (dd, 1H), 7.42 (dd, 1H), 7.76 (d, 1H), 10.43 (s, 1H). 
13C NMR (75 MHz, CDCl3) 6-4.40, 18.26, 25.57, 120.12, 121.36, 127.12, 128.21, 
135.62, 158. 79, 189.98. 
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Preparation of (2-Methoxy-6-methylphenyl}methanol (42). 
To a stirred solution of 2.89 g (19.2 mmol) of 38 dissolved in 100 ml of a 
4: 1 methanol-CH 2Cl2 solution at O °C was slowly added 3.64 g (96.2 mmol) of 
NaBH4. After allowing the reaction mixture warm to RT over 14 h, the mixture 
was quenched with acetone and water, then diluted with CH2Cl2. The pH was 
adjusted to 3.0 by 1.0 M HCI. The organic layer was washed with a saturated 
solution of NaCl, dried and evaporated, leaving a yellow oil. The oil was 
subjected to silica gel column chromatography (4:1 petroleum ether-ethyl 
acetate), yielding 2.53 g of 42 as a yellow-white solid. The product was 
crystallized from petroleum ether-ethyl acetate, yielding 2.14 g (73.0%) of 42 as 
white crystals; mp 51.2-52.1 °C (lit.76 51-52 °C). 1H NMR (300 MHz, CDCl3) 
l52.31 (br s, 1 H), 2.38 (s, 3H), 3.85 (s, 3H), 4.74 (s, 2H), 6.75 (d, 1 H), 6.80 
(d,1H), 7.16 (dd, 1H). 13C NMR (75 MHz, CDCl3) l519.12, 55.42, 57.42, 108.14, 
122.97, 127.08, 128.50, 137.77, 158.03. 
Synthesis of 2-Methoxymethyl-3-methylanisole (43). 
In a 100-ml round-bottom flask, 0.61 g (15.3 mmol) of a 60% suspension 
of NaH in mineral oil was washed with petroleum ether, then immersed in 25 ml 
of anhydrous THF. The flask was fitted with a rubber septum and positive-
pressure nitrogen line, then cooled to -78 °C. To this mixture was added 1.06 g 
(7.0 mmol) of 42 dissolved in 15 ml of anhydrous THF. The flask was warmed 
to O °C over 1 h, at which time 1.0 ml (10.6 mmol) of Me2S0 4 was added, and 
the mixture was allowed to warm to RT and stir for 16 h. The mixture was 
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quenched with 1.0 M NaOH and extracted with ethyl ether, which was stirred with 
additional 1.0 M NaOH for 3 h. The organic layer was washed with a saturated 
solution of NaCl, dried and concentrated, yielding 0.97 g (83.6%) of 43 as a clear 
oil. 1H NMR (300 MHz, CDCl3) <5 2.38 (s, 3H), 3.38 (s, 3H), 3.82 (s, 3H), 4.55 (s, 
2H), 6.74 (d, 1 H), 6.80 (d, 1 H), 7.17 (dd, 1 H). 13C NMR (75 MHz, CDCl3) <5 
19.05, 55.71, 58.09, 65.26, 108.30, 122.74, 124.30, 128.88, 139.87, 158.22. 
Synthesis of 3-Methyl-2-vinylanisole (41). 
To a stirred solution of 8.15 g (22.8 mmol) of methyltriphenylphosphonium 
bromide in 150 ml of anhydrous THF under nitrogen was added 15.0 ml (24.0 
mmol) of a 1.6 M solution of n-Buli in hexane.37•38 After 20 min, a solution of 
3.17 g (21.1 mmol) of aldehyde 38 dissolved in 24 ml of anhydrous THF was 
injected, and stirring was continued. After an additional 45 min, the reaction was 
quenched with water and diluted with ethyl ether. The organic layer was washed 
several times with water and a saturated solution of NaCl, dried and 
concentrated. Any remaining phosphonium by-products were removed by 
precipitating out a majority of the phosphonium impurities from ethyl acetate. 
The filtrate was subjected to silica gel column chromatography (8: 1 petroleum 
ether-ethyl acetate), yielding 2.42 g (77.3%) of 41 as an oil. 1H NMR (300 MHz, 
CDCl3) <5 2.36 (s, 3H), 3.82 (s, 3H), 5.52 (dd, J = 11.7, 2.4 Hz, 1 H), 5.64 (dd, J = 
18.0, 2.4 Hz, 1H), 6.73 (d, 1H), 6.78 (d, 1H), 6.79 (d, J= 18.0 Hz, 1H), 7.11 (dd, 
1H). 13C NMR (75 MHz, CDCl3) <5 20.80, 55.46, 108.27, 119.33, 122.95, 126.04, 
127.50, 131.17, 137.40, 157.58. 
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Synthesis of 2-Methoxy-6-methylbenzoic Acid (44). 
To a stirred solution of 6.35 g (42.3 mmol) of 38 in 50 ml of CH3CN was 
added 4.8 ml (58.3 mmol) of a 35% wt solution of H2O2 in water and 1.4 g (10.1 
mmol) of NaH2PO4 in 20 ml of water. The reaction flask was cooled to 5 °C and 
fitted with a pressure-equalizing addition funnel and bubbler line. A solution of 
6.68 g (59.1 mmol) of NaCIO2 in 70 ml of water was added dropwise from the 
funnel over 30 min. Release of oxygen gas was monitored by the bubbler. After 
gas evolution ceased (about 1 h), 0.8 g of Na2SO3 was added to destroy any 
remaining HOCI (generated in situ) and H2O2. The reaction mixture was acidified 
with 10% HCI and extracted with ethyl acetate. The organic layer was separated, 
washed with a saturated solution of NaCl, dried and concentrated. The crude 
organic residue was crystallized with ethyl ether-petroleum ether yielding pale-
yellow crystals which were further crystallized in water yielding 2.04 g (29.1 %) of 
44 as white crystals; mp 138.0-138.5 °C (lit.36 138-139 °C; lit.76 137-139 °C). 1H 
NMR (300 MHz, CDCl3) ~ 2.50 (s, 3H), 3.93 (s, 3H), 6.84 (d, 1 H), 6.88 (d, 1 H), 
7.32 (dd, 1H). 13C NMR (75 MHz, CDCl3) ~ 20.80, 56.29, 108.83, 120.81, 
123.45, 139.67, 157.19, 170.42. 
Synthesis of 2-tert-Butyldimethylsilyloxybenzoic Acid (89). 
A 100-ml round-bottom flask was fitted with a rubber septum and positive-
pressure nitrogen line and charged with a solution of 0.53 g (3.8 mmol) of 
salicylic acid in 50 ml of anhydrous CH2Cl2• To the flask was added a solution of 
0.59 g (3.9 mmol) of TBSCI and 0.06 g (0.5 mmol) of DMAP in 10 ml of 
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anhydrous THF. After 10 min, 0.6 ml (4.3 mmol) of Et3N was injected via 
syringe and stirring was continued for 5 h. The reaction was quenched with a 
saturated solution of NH4CI. The organic layer was rinsed with additional NH4CI, 
water and a saturated solution of NaCl, then dried and concentrated. The crude 
organic oil was subjected to silica gel column chromatography (5:2 petroleum 
ether-ethyl acetate) then crystallized from ethyl acetate-petroleum ether, 
yielding 0.12 g (12.4%) of 89, as white crystals. 1H NMR (300 MHz, CDCl3) ~ -
0.07 (s, 6H), 0.81 (s, 9H), 4.28 (br s, 1 H), 6.88-6.95 (m, 2H), 7.49 (dd, 1 H), 7. 77 
(dd, 1H). 13C NMR (75 MHz, CDCl3) ~ -3.12, 25.89, 112.98, 117.20, 119.32, 
130.38, 135.80, 161.23, 172.07. 
5. Synthesis of Alkyne Synthon 
Preparation of Benzyloxyacetic acid (63). 
In a 250-ml round-bottom flask, fitted with a rubber septum and positive-
pressure nitrogen line, was added 64.86 g (0.60 mol) of benzyl alcohol and 3.79 
g (164.8 mmol) of sodium metal, and the mixture was heated to 95 °C to fully 
dissolve the metal. Once the sodium was fully dissolved, 20.11 g (172.6 mmol) 
of sodium chloroacetate was added. The flask was fitted with a condenser and 
warmed to 165 °C for 38 h. Concurrently, a second reaction was run using the 
same procedure with 68.49 g (0.6 mol) of benzyl alcohol, 3.94 g (171.3 mmol) of 
sodium metal and 20.37 g (174.9 mmol) of sodium chloroacetate. Once cooled 
to RT, the reaction mixtures were combined, and the excess benzyl alcohol was 
distilled (55 °C/0.15 torr) away from the remaining waxy product. To this product 
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400 ml of ethyl ether and 400 ml of water were added and the pH was adjusted 
to 1.92 with 1.0 M HCI. The organic layer was separated and the aqueous layer 
was washed with several 50-ml portions of ethyl ether. The organic layers were 
combined, dried and concentrated. Any residual benzyl alcohol was removed via 
distillation (56 °C/0.2 torr). Distillation of the product yielded 39.73 g (71.1 %) of 
63 as a clear oil; bp 124 °C/0.15 torr (lit.79 114-115 °C/0.08 torr). 1H NMR (300 
MHz, CDCl3) ~ 4.12 (s, 2H), 4.62 (s, 2H), 7.29-7.36 (m, SH), 10.44 (br s, 1 H). 
13C NMR (75 MHz, CDCl3) ~ 66.35, 73.22, 127.97, 128.29, 128.43, 136.47, 
175.54. 
Synthesis of 2-Benzyloxy-N-methoxy-N-methylacetamide (64). 
In a 500-ml round-bottom flask was added 13. 70 g (82.4 mmol) of 63, 
14.92 g (92.0 mmol) of COi and 180 ml of anhydrous THF. The mixture was 
stirred for 1 h, where all CO2 evolution had ceased.61•62 Next, 8.29 g (85.0 mmol) 
of N, O-dimethylhydroxyamine hydrochloride was added, and the reaction was 
stirred for 50 h. After filtration, the filtrate was diluted with 100 ml of ethyl ether 
and extracted with several portions of a 1.0 M solution of HCI, followed by a 
saturated solution of NaCl. The organic layer was dried and concentrated, 
yielding a clear organic liquid. The product was distilled at 115 °C/0.15 torr, and 
GC/MS was used to determine the purity of the distillate. The product was stirred 
with pre-charged Amberlite IRA-400 [OH·] ion-exchange resin in ethanol for 20 
min to remove remaining benzyloxyacetic acid. The resin was filtered off, and 
the ethanol was evaporated, yielding 13.43 g (77.9%) of 64 as a clear oil. 1H 
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NMR (300 MHz, CDCl3) ~ 3.18 (s, 3H), 3.62 (s, 3H), 4.29 (s, 2H), 4.67 (s, 2H), 
7.35-7.38 (m, SH). 13C NMR (75 MHz, CDCl3) ~ 61.37, 67.31, 73.21, 127.82, 
128.03, 128.42, 128.51, 137.45, 221.43. 
Synthesis of 1-Benzyloxy-4-trimethylsilylbut-3-yn-2-one (65). 
A 100-ml round-bottom flask, fitted with a rubber septum and positive-
pressure nitrogen line, was charged with 0.30 g (3.0 mmol) of 
trimethylsilylacetylene, 1.8 ml (2.9 mmol) of a 1.6 M solution of n-Buli in hexane 
and 40 ml of anhydrous THF and cooled to -78 °C.80 After the reaction mixture 
was allowed to stand for 30 min, a solution of 0.31 g (1.5 mmol) of 64 dissolved 
in 5 ml of anhydrous THF was slowly injected via syringe. The reaction flask 
was warmed to -1 O °C over 1 hand allowed to stand at this temperature for 
another 1 h. The mixture was cooled to -78 °C, quenched with glacial HOAc, 
then warmed to O 0 c, at which time 20 ml of a saturated NaCl solution was 
added along with 20 ml of ethyl ether. The organic layer was removed and 
washed with additional saturated NaCl solution, while the aqueous layer was 
washed with several portions of ethyl ether. The organic layers were combined, 
washed with several portions of a saturated NaHCO3 solution, dried and 
concentrated, yielding 0.35 g (98.0%) of 65 as a dark red oil. 1H NMR (300 MHz, 
CDCl3) ~ 0.24 (s, 9H), 4.23 (s, 2H), 4.64 (s, 2H), 7.37 (m, SH). 13C NMR (75 
MHz, CDCl3) ~ -0.88, 73.34, 75.71, 99.71, 101.27, 127.92, 128.02, 128.47, 
137.01, 184.66. EIMS (70 eV) m/z: M+ 246.1 (12), 223.1 (47), 201.1 (19), 173.1 
(52), 140.0 (96), 125.0 (100). 
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Synthesis of 3-Benzyloxymethyl-5-trimethylsilanyl-pent-1-en-4-yn-3-ol (66). 
To a stirred solution of 0.34 g (1.4 mmol) of 65 in 40 ml of anhydrous 
THF, under nitrogen and at -78 °c, was added via syringe 5.0 ml of a 1.0 M 
solution of vinylmagnesium bromide in hexane. The reaction mixture was 
allowed to slowly warm to RT over 18 h, then the reaction was cooled to 0 °C and 
quenched with a saturated NH4CI solution and diluted with ethyl ether. After 
separation, the aqueous layer was washed with several small portions ethyl 
ether. The organic layers were combined, washed with a saturated NaCl 
solution, dried and evaporated, yielding 0.38 g (99.7%) of 66 as a dark oil, which 
was used without further purification. 1H NMR (300 MHz, CDCl 3) ~ 0.19 (s, 9H), 
2.92 (br s, 1 H), 3.49 (d, J = 9.3 Hz, 1 H), 3.58 (d, J = 9.3 Hz, 1 H), 4.68 (s, 2H), 
5.27 (d, J= 10.2 Hz, 1H), 5.63 (d, J= 17.1 Hz, 1H), 5.91 (dd, J= 17.0, 10.0 Hz, 
1 H), 7.35 (m, SH). 13C NMR (75 MHz, CDCl3) ~ -0.15, 71.09, 73.55, 76.42, 
90.56, 104.54, 116.69, 127.60, 127.75, 128.40, 137.30, 137.76. 
Synthesis of 3-Benzyloxymethyl-pent-1-en-4-yn-3-ol (67). 
In a 100-ml round-bottom, chilled to O 0 c and under nitrogen, was placed 
40 ml of anhydrous methanol and 0.38 g (1.4 mmol) of 66. To this stirred 
solution was injected via syringe a catalytic amount of a 25 wt % solution of 
sodium methoxide in methanol. 6 The flask was warmed to RT for 3 h before 
being quenched with a saturated NH4CI solution and extracted with ethyl ether. 
The aqueous layer was washed with several small portions of ethyl ether. The 
organic layers were combined, washed with water, washed with a saturated NaCl 
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solution, dried and evaporated. The crude product was purified by silica gel 
column chromatography (9:1 petroleum ether-ethyl acetate) yielding 0.24 g 
(87.4%) of 67 as a pale-yellow oil. 1H NMR (300 MHz, CDCl3) l> 2.59 (s, 1 H), 
2.98 (br s, 1 H), 3.49 (d, J = 9.3 Hz, 1 H), 3.59 (d, J = 9.3 Hz, 1 H), 4.68 (s, 2H), 
5.29 (d, J = 10.5 Hz, 1 H), 5.64 (d, J = 16.8 Hz, 1 H), 5.91 (dd, J = 17.1, 10.5 Hz, 
1 H), 7.34 (m, SH). 13C NMR (75 MHz, CDCl3) l> 70.67, 73.71, 73.86, 76.36, 
83.29, 117.02, 127.72, 127.86, 128.45, 136.92, 137.49. Anal. Calcd for 
C13H14O2: C, 77.20; H, 6.98. Found: C, 77.37; H, 6.98. 
Synthesis of 1-Benzyloxy-2-oxiranyl-but-3-yn-2-ol (87). 
To a solution of 0.56 g (2.8 mmol) of 67 in 75 ml of anhydrous CH2Cl2 at 0 
°C under nitrogen was added 0.99 g (5.8 mmol) of m-CPBA and 1.22 g (8.6 
mmol) of Na2HPO4. After the reaction mixture was stirred at RT for 17 h, it was 
diluted with a saturated solution of Na2S2O3 and a saturated solution of NaHCO3 
and extracted with ethyl acetate. The organic layer was washed with water, a 
saturated solution of NaCl, dried and concentrated. The crude organic residue 
was subjected to silica gel column chromatography (6:1 petroleum ether-ethyl 
acetate), yielding 0.13 g (21.5%) of 87 as a pale yellow oil. 1H NMR (300 MHz, 
CDCl3) l> 2.50 (s, 1 H), 2.77 (m, 1 H), 2.94 (m, J = 10.0, 5.1, 2.7 Hz, 1 H), 3.10 (d, 
J = 9.3 Hz, 1 H), 3.26 (m, 1 H), 3.67 (m, 1 H), 4.65 (s, 2H), 7.33 (m, SH). 13C NMR 
(75 MHz, CDCl3) l> 43.89, 54.26, 68.64, 73.63, 73.89, 74.39, 81.33, 127.59, 
127.75, 128.34, 137.36. ESI-MS (m/z): [M + Nat calcd for C13H14O3, 241.2; 
found 241.0; [M + Kt calcd for C13H140 3, 257.3; found 256.9. 
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6. Alkynyl Coupling Procedures 
Svnthesis of 1-(2-tert-Butvldimethvlsilvloxv-6-methvlphenvl)-4-methvl-hex-5-en-2-
vne-1 ,4-diol {82). 
To a solution of methylmagnesium bromide (1.8 ml, 3M in ethyl ether, 5.4 
mmol) in 1 0 ml of anhydrous THF was added a solution of 0.241 g (2.51 mmol) 
of the acetylene in 1 O ml of anhydrous THF at O °C under nitrogen and the 
mixture stirred at 50 °C for 3 h. A solution of 0.609 g (2.43 mmol) of 81 dissolved 
in 5 ml of anhydrous THF was added at RT, and the entire reaction mixture 
stirred for an additional 2 h. The reaction mixture was quenched with a saturated 
solution of NH4CI and extracted with several portions of ethyl acetate. The 
organic layers were combined, extracted with a saturated solution of NaCl, 
separated, dried and concentrated. The crude organic residue was subjected to 
silica gel column chromatography. The initial solvent system was 6: 1 petroleum 
ether-ethyl acetate to elute remaining aldehyde 81, then solvent system slowly 
changed to 1: 1 petroleum ether-ethyl acetate to elute product. The reaction 
yielded 0.54 g (63.8%) of 82 isolated as a white solid. 1H NMR (300 MHz, 
CDCl3) ~ 0.27 (s, 6H), 1.04 (s, 9H), 1.48 (s, 3H), 2.45 (s, 3H), 3. 78 (d, 1 H), 5.03 
(dd, 1 H, J = 6.2, 10.2 Hz), 5.39 (dd, 1 H, J = 17.4, 10.2 Hz), 5.92 (m, 2H), 6.68 (d, 
1 H), 6.76 (d, 1 H), 7.04 (dd, 1 H). 13C NMR (75 MHz, CDCl3) ~ -4.03, 18.40, 
19.85, 26.05, 29.85, 59.38, 68.21, 84.80, 86.15, 113.48, 116.44, 124.00, 128.30, 
128.77, 137.32, 141.65, 153.12. Anal. CalcdforC 20H300 3Si: C, 69.32; H, 8.73. 
Found: C, 69.05; H, 8.93. 
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Synthesis of 4-Benzyloxymethyl-1-[2-(tert-butyldimethylsi lyloxy)-6-methylphenyll-
hex-5-en-2-yne-1 ,4-diol (83) via the Bromomagensium Salt of 67. 
In a 100-ml round-bottom flask, a solution of methyl magnesium bromide 
(4.8 ml, 3M in ethyl ether, 14.4 mmol) in 5 ml of anhydrous THF was cooled to 
0 °C and placed under nitrogen. A solution of 1.45 g (7.2 mmol) of acetylene 67 
dissolved in 1 0 ml of anhydrous THF was added with syringe and the reaction 
mixture was warmed to 50 °C for 2 h. At this point the reaction was cooled to RT 
and a solution of 1.60 g (6.4 mmol) of aldehyde 81 dissolved in 5 ml of 
anhydrous THF was added via syringe. After stirring for 14 hat RT, the reaction 
mixture was quenched with a saturated solution of NH4CI and extracted with 
several portions of ethyl acetate. The organic layers were combined, extracted 
with a saturated solution of NaCl, separated, dried and concentrated. The crude 
organic residue was subjected to silica gel column chromatography (6:1 
petroleum ether-ethyl acetate; R, = 0.06) to elute starting material, then the 
solvent was changed (3:1 petroleum ether-ethyl acetate; R, = 0.30) yielding 1.51 
g (52.2%) of 83 as a yellow oil. 1H NMR (300 MHz, CDCl3) <5 0.28 (s, 6H), 1.02 
(s, 9H), 2.23 (s, 1 H), 2.44 (s, 3H), 2.91 (br s, 1 H), 3.45 (d, 1 H), 3.52 (d, 1 H), 4.58 
(s, 1 H), 5.20 (d, 1 H), 5.53 (d, 1 H), 5.82-5.93 (m, 2H), 6.66-6.79 (m, 2H), 7.05 
(dd, 1H), 7.27-7.34 (m, SH). 13C NMR (75 MHz, CDCl3) <5-3.97, 18.25, 19.76, 
25.91, 59.14, 70.77, 73.55, 76.41, 83.82, 85.79, 116.50, 124.14, 127.62, 128.36, 
128.68, 137.26, 137.35, 137.56, 137.63, 137.67, 153.17. ESI-MS (m/z): [M + 
Nat calcd for C27H360 4Si, 475.2; found 475.1; [M + Kt calcd for C27H360 4Si, 
491.2; found 491.0. 
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Synthesis of 4-Benzyloxymethyl-1-[2-(terl-butyldi methylsi lyloxy)-6-methylphenyl)-
hex-5-en-2-yne-1 ,4-diol (83) via the Lithium Salt of 67. 
In a 50-ml round-bottom flask, a solution of 6.4 ml (1.6 M; 10.2 mmol) of 
n-Buli in 3 ml of anhydrous THF was cooled to 0 °C and placed under nitrogen. 
To this solution was added 1.02 g (5.0 mmol) of 67 dissolved in 5 ml of 
anhydrous THF via syringe and stirring continued at O °C for 15 min. Next, a 
solution of 1.20 g (4.8 mmol) of 81 dissolved in 3 ml of anhydrous THF was 
added and stirring continued at O °C for 30 min and at RT for 4 h. The reaction 
was quenched with a saturated solution of NH4CI and diluted with ethyl acetate. 
The organic layer was washed with water and a saturated solution of NaCl, then 
dried and concentrated. The resulting organic residue was subjected to silica gel 
column chromatography (6: 1 petroleum ether-ethyl acetate; R, = 0.06) to elute 
starting material then the solvent was changed (3: 1 petroleum ether-ethyl 
acetate; R, = 0.31 ), yielding 0.55 g (25.3%) of 83 as a pale yellow oil. 1H NMR 
(300 MHz, CDCl3) 6 0.27 {s, 6H), 1.02 {s, 9H), 2.23 (s, 1 H), 2.43 {s, 3H), 2.90 (br 
s, 1 H), 3.43 {d, 1 H), 3.51 (d, 1 H), 4.58 (s, 1 H), 5.19 (d, 1 H), 5.52 (d, 1 H), 
5.80-5.92 (m , 2H), 6.65--6.79 {m, 2H), 7.05 (dd, 1 H), 7.27-7.33 (m, SH). 13C 
NMR (75.5 MHz, CDCl3) 6 -3.98, 18.25, 19.77, 25.92, 59.15, 70.79, 73.56, 76.42, 
83.84, 85.81, 116.53, 124.19, 127.63, 128.39, 128.71, 137.28, 137.36, 137.59, 
137.65, 137.70, 153.20. ESI-MS (m/z): [M + Nat calcd for C27H360 4Si, 475.2; 




To a solution of 0.13 g (0.6 mmol) of 87 in 20 ml of anhydrous THF, 
cooled to -78 °C, was added 0.8 ml (1.3 mmol) of a 1.6 M solution of n-Buli in 
hexane. After the solution was stirred for 20 min, a solution of 0.19 g (0.8 mmol) 
of 81 dissolved in 3 ml of anhydrous THF was injected via syringe and stirring 
continued for 2 hat -78 °C. The reaction was quenched with a saturated solution 
of NH4CI and diluted with ethyl acetate. The organic layer was separated and 
washed with water and a saturated solution of NaCl, then dried and 
concentrated. The crude organic residue was subjected to silica gel column 
chromatography (6:1 petroleum ether-ethyl acetate), yielding 56 mg (20.0%) of 
88 as a yellow oil. 1H NMR (300 MHz, CDCl3) ~ 0.23 (s, 6H), 0.92 (s, 9H), 1.3 (br 
s, 1 H), 2.27 (s, 3H), 2.71-2.90 (m, 3H), 3.21 (m, 1 H), 3.63 (m, 2H), 4.58 (m, 2H), 
5.78 (s, 1 H), 6.65 (d, 1 H), 6.75 (d, 1 H), 7.08 (dd, 1 H), 7.27-7.34 (m, SH). 
Synthesis of 4-Benzyloxymethyl-1-[2-(tert-butyldimethylsilyloxy)-6-
methylphenyl]-4-hydroxy-hex-5-en-2-yn-1-one (84). 
In a 25-ml round-bottom flask, fitted with a condenser and a positive-
pressure nitrogen line, was placed 0.32 g (0. 70 mmol) of 83 dissolved in 15 ml 
of anhydrous toluene and 3.12 g (35.9 mmol) of MnO2• The mixture was refluxed 
for 5 h then filtered through a Celite pad using ethyl acetate and ethyl ether. 
After the solvent was evaporated, the resulting yellow residue was subjected to 
silica gel column chromatography (7:1 petroleum ether-ethyl acetate; R, = 0.23), 
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yielding 74 mg (23.5%) of 84 as a yellow oil. 1H NMR (300 MHz, CDCl3) l) 0.19 
(s, 6H), 0.95 (s, 9H), 2.29 (s, 3H), 3.12 (br s, 1 H), 3.49 (d, 1 H), 3,60 (d, 1 H), 4.62 
(s, 2H), 5.29 (d, J = 10.5 Hz, 1 H), 5.60 (d, J = 17.1 Hz, 1 H), 5.83 (dd, J = 17.1, 
10.4 Hz, 1H), 6.67 (d, 1H), 6.78 (d, 1H), 7.15 (dd, 1H), 7.30 (m, SH). IR: 1697 
cm·1. ESI-MS (m/z): [M + Ht calcd for C27H340 4Si, 451.2; found 451.0; [M + Nat 
calcd for C27H340 4Si, 473.2; found 473.0; [M + Kt calcd for C27H340 4Si, 489.2; 
found 489.0. 
Synthesis of 2-(1-Benzyloxymethyl-1-hydroxyallyl}-5-methylchromen-4-one (85). 
In a 25-ml round-bottom flask, fitted with a rubber septum and positive-
pressure nitrogen line, was placed 74 mg (160 µmol) of 84, 96 mg (360 µmol) of 
18-crown-6 and 5 ml of anhydrous □MF. To this solution at 0 °C was added 28 
mg (480 µmol) of spray-dried KF.1·7 The reaction was allowed to stirred at RT for 
2 h. The reaction mixture was quenched with a saturated NH4CI solution and 
extracted with ethyl acetate. The organic layer was washed with a saturated 
NaCl solution, dried, and concentrated. The crude organic residue was 
subjected to silica gel column chromatography (3:1 petroleum ether-ethyl 
acetate; R, = 0.14), yielding 53 mg (96.3%) of 85 as a yellow oil. 1H NMR (300 
MHz, CDCl3) l) 2.63 (s, 3H), 3.63 (d, 1 H), 3.75 (d, 1 H), 4.61 (dd, 2H), 5.26 (d, J = 
10.8 Hz, 1H), 5.49 (d, J= 17.1 Hz, 1H), 6.07 (dd, J= 17.3, 10.7 Hz, 1H), 6.14 (s, 
1 H), 6.92 (d, 1 H), 6.98 (d, 1 H), 7.30 (m, SH), 7.46 (dd, 1 H). 13C NMR (75 MHz, 
CDCl3) l) 17.78, 73.60, 75.22, 75.45, 109.91, 115.64, 119.25, 124.81, 127.68, 
127.76, 127.93, 128.33, 128.38, 136.67, 137.67, 140.25, 147.12, 166.44, 184.98. 
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ESI-MS (m/z): [M + Ht calcd for C21H20O4 , 337.1; found 336.9; [M + Nat calcd 
for C21H20O4 , 359.1; found 359.0; [M + Kt calcd for C21H20O4 , 375.1; found 374.9. 
Synthesis of 2-(2-Benzyloxy-1-hydroxy-1-oxiranylethyl}-5-methylchromen-4-one 
(86). 
To a stirred solution of 0.15 g (0.5 mmol) of 85 and 0.33 g (2.3 µmol) of 
Na2HPO4 in 1 O ml of anhydrous CH2Cl2 was added 0.47 g (2.8 mmol) of m-
CPBA at O °C. After the reaction mixture was stirred at RT for 10 h, it was 
quenched with a saturated solution of Na2S2O3 and a saturated solution of 
NaHCO 3 then extracted with ethyl acetate. The organic layer was washed with a 
saturated solution of NaCl, then it was dried and concentrated. The crude 
organic residue was subjected to silica gel column chromatography (1: 1 
petroleum ether-ethyl acetate; R, = 0.11) and the final product crystallized from 
petroleum ether-ethyl acetate, yielding 12 mg (7.6%) of 86 as pale-yellow 
crystals. 1H NMR (300 MHz, CDCl3} b 2.86 (s, 3H}, 2.96 (dd, 1 H}, 3.52 (dd, 1 H), 
3.77 (d, 1 H}, 3.91 (d, 1 H}, 4.12 (dd, 1 H}, 4.58 (dd, 2H), 6.63 (s, 1 H}, 7.21-7.48 
(m, 6H}, 7.59 (d, 1 H}, 8.00 (d, 1 H). 13C NMR (75 MHz, CDCl3} b 22.75, 43.55, 
53.15, 65.16, 70.58, 73.71, 100.125, 111.08, 111.36, 115.82, 127.65, 127.79, 
128.54, 129.59, 132.62, 133.22, 133.60, 139.47, 188.68. ESI-MS (m/z): [M + Ht 
calcd for C21H20O5, 353.4; found 353.2; [M + Nat calcd for C21H20O5, 375.4; found 
375.3; [M + Kt calcd for C21H20O5, 391.5; found 391.3. 
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Synthesis of 2-(1 ,2-Dihydroxy-1-oxiranylethyl)-5-methylchromen-4-one (1 ). 
In a 25-ml round-bottom flask was placed 12 mg (34 µmol) of 86 
dissolved in 7 ml of anhydrous ethyl acetate along with 82 mg of 10% palladium-
on-carbon. After the flask was fitted with a magnetic stirbar and a rubber 
septum, hydrogen gas was introduced to the flask. The reaction was allowed to 
stir for 20 h, after which the hydrogen gas source was removed and the mixture 
was passed through a small portion of Celite to remove the carbon. The crude 
material was purified via a silica gel preparative plate (3:5 petroleum ether-ethyl 
acetate; R, = 0.21 ), yielding 2 mg (22.4%) of 1 as a pale solid. 1H NMR (300 
MHz, CDCl3) 0 2.81 (s, 3H), 3.84 (dd, 2H), 4.12 (dd, 1 H), 4.22 (dd, 2H), 6.84 (s, 
1 H), 7.48 (dd, J = 7.5, 7.6 Hz, 1 H), 7.61 (d, J = 7.2 Hz, 1 H), 8.11 (d, J = 7.2 Hz, 
1 H). 13C NMR (75 MHz, CDCl3) ~ 24.32, 39.93, 53.74, 71.34, 123.96, 125.23, 
125.93, 127.68, 129.05, 129.97, 131.17, 164.24, 169.99, 185.86. ESI-MS (m/z): 
[M + Ht calcd for C14H140 5, 263.3; found 000.0; [M + Nat calcd for C14H140 5, 
285.2; found 000.0; [M + Kt calcd for C14H140 5, 301.3; found 000.0. 
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1H NMR Spectrum (300 MHz, CDCl3) of 7-Bromo-1-hydroxy-6-methylanthraquinone (35). 
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1H NMR Spectrum (300 MHz, CDCl3) of Ethyl 2-Hydroxy-6-methylbenzoate (17). 
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1H NMR Spectrum (300 MHz, CDCl3) of 
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13C NMR Spectrum (75 MHz, CDCl3) of 
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3, 4-B is-( tert-butyld imethyl si lyloxy )-3-(2-methoxy-ethoxymethoxymethyl )-but-1-ene ( 57). 
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1H NMR Spectrum (300 MHz, CDCl 3} of 
3-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-3-hydroxy-1-(2-hydroxyphenyl)-propan-1-one (7 4 ). 
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13C NMR Spectrum (75 MHz, CDCl3) of 









7 6 5 4 3 2 1 









1111111 I 11 11 111 11 11111Ii1111 1111111 111 I 11 I 11II'I1111111111111I11111111111 11111 11 11 i I I I I I I I I Ii I 111 I 11 11 11 I 11 111 I 
200 180 160 140 120 100 80 60 40 20 












Li Ju L . Jl . a, 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
10 9 8 7 6 5 4 3 2 
1H NMR Spectrum (300 MHz, CDCl3) of 2-Methoxy-6-methylbenzaldehyde (38). 
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1H NMR Spectrum (300 MHz, CDCl3 ) of 2-Methoxy-6-methylacetophenone (40). 
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1H NMR Spectrum (300 MHz, CDCl3} of 6-Methylsalicylaldehyde (80). 
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1H NMR Spectrum (300 MHz, CDCl3) of 2-(tert-Butyldimethylsilyloxy)benzaldehyde (79). 
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1H NMR Spectrum (300 MHz, CDCl 3) of 2-Methoxymethyl-3-methylanisole (43). 
1 








I I I II I I 
200 180 160 140 120 100 80 60 40 20 ppm 







I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
8 7 6 5 4 3 2 1 ppm 







• .. I 1~W 
I I I I I I I I I I I' I I I I I I I I I' I I I I I I I I I I I I I I I I I I 11 I I I I I I I I I I I I I I I I I I I I I I I I I I I I 11 I I I JI I I I 11 I I I I I I I I 11 I I I I I I I I 
200 180 160 140 120 100 80 60 40 20 ppm 





































~ l-~---1 •• ,. •. ~~ 11 I I I (II I I 11 I I I (II I I 11 I I I (II 11 11 I I I ( I 11 I 11 I I I (II I I 11 I I I (II I I 11 I I I (II I I 11 I I I (II I I 11 I I I (II I I 11 I I I I I I I I 
200 180 160 140 120 100 80 60 40 20 ppm 







I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
12 11 10 9 8 7 6 5 4 3 2 ppm 








I' I I I 11 I I I I' I I I 11 I I I I' I 11 11 I 11 I' I I I 11 I I I I' I I I 11 I I I I' I I I 11 I I I I' I 11 11 I 11 I' I I I 11 I I I I' I I I 11 I I I I' I I I I I I I I 
200 180 160 140 120 100 80 60 40 20 ppm 










I I I I I 
8 
J~ 
I I I I I I I I I I I I I 
7 6 
)L)LL__JLJ~ ____i 
I I I I I I I I I I I I I I I I I I I I 
5 4 3 2 
1H NMR Spectrum (300 MHz, CDCl3} of 2-Benxyloxy-N-methoxy-N-methylacetamide (64). 
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1H NMR Spectrum (300 MHz, CDCl 3) of 1-Benzyloxy-4-trimethylsilyl-but-3-yn-2-one (65). 
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13C NMR Spectrum (75 MHz, CDCl 3) of 
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13C NMR Spectrum (75 MHz, CDCl3} of 
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13C NMR Spectrum (75 MHz, CDCl3) of 
2-(1-Benzyloxymethyl-1-hydroxyallyl)-5-methylchromen-4-one (85). 
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13C NMR Spectrum (75 MHz, CDCl3) of 2-(2-Benzyloxy-1-hydroxy-1-oxiranylethyl)-5-methylchromen-4-one (86). 
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